Document
00.8400.000.00false--12-31Q320180000727892falseNon-accelerated Filerfalse540000000160000001600000020764000000209280000000303010000010000010000010000010000010000000.00710.00710.00830.00830.00830000000000001200000050000000100000000
0000727892
2018-01-01
2018-09-30
0000727892
2018-11-05
0000727892
2018-09-30
0000727892
2017-12-31
0000727892
2017-07-01
2017-09-30
0000727892
2018-07-01
2018-09-30
0000727892
2017-01-01
2017-09-30
0000727892
us-gaap:RetainedEarningsMember
2018-09-30
0000727892
us-gaap:AdditionalPaidInCapitalMember
2017-09-30
0000727892
us-gaap:CommonStockMember
2017-09-30
0000727892
us-gaap:RetainedEarningsMember
2017-01-01
2017-09-30
0000727892
us-gaap:RetainedEarningsMember
2017-12-31
0000727892
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2016-12-31
0000727892
us-gaap:AdditionalPaidInCapitalMember
2018-09-30
0000727892
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0000727892
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-09-30
0000727892
us-gaap:CommonStockMember
2017-12-31
0000727892
us-gaap:RetainedEarningsMember
2018-01-01
2018-09-30
0000727892
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-12-31
0000727892
us-gaap:CommonStockMember
2016-12-31
0000727892
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-01-01
2017-09-30
0000727892
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-09-30
0000727892
us-gaap:AdditionalPaidInCapitalMember
2016-12-31
0000727892
2017-09-30
0000727892
us-gaap:RetainedEarningsMember
2016-12-31
0000727892
us-gaap:RetainedEarningsMember
2017-09-30
0000727892
2016-12-31
0000727892
us-gaap:CommonStockMember
2018-09-30
0000727892
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-09-30
0000727892
amp:IncomeTaxProvisionMember
2017-01-01
2017-03-31
0000727892
us-gaap:AccountingStandardsUpdate201409Member
us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member
2017-07-01
2017-09-30
0000727892
us-gaap:AccountingStandardsUpdate201409Member
us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member
2017-01-01
2017-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenuesFromContractswithCustomersMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
srt:AffiliatedEntityMember
2018-01-01
2018-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
amp:UnaffiliatedMember
2017-07-01
2017-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
amp:UnaffiliatedMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
2017-01-01
2017-09-30
0000727892
amp:OtherRevenuesFromContractswithCustomersMember
2017-01-01
2017-09-30
0000727892
amp:OtherRevenueOtherFeesMember
srt:AffiliatedEntityMember
2017-07-01
2017-09-30
0000727892
amp:OtherRevenueOtherFeesMember
amp:UnaffiliatedMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
amp:UnaffiliatedMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
srt:AffiliatedEntityMember
2017-01-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
srt:AffiliatedEntityMember
2017-07-01
2017-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
2017-07-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
2018-01-01
2018-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
srt:AffiliatedEntityMember
2017-01-01
2017-09-30
0000727892
amp:OtherRevenueOtherFeesMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
amp:UnaffiliatedMember
2017-01-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
amp:UnaffiliatedMember
2017-07-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
srt:AffiliatedEntityMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
2017-01-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
2017-07-01
2017-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
srt:AffiliatedEntityMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
srt:AffiliatedEntityMember
2018-07-01
2018-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
srt:AffiliatedEntityMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenuesFromContractswithCustomersMember
2017-07-01
2017-09-30
0000727892
amp:OtherRevenuesFromContractswithCustomersMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenueOtherFeesMember
2018-01-01
2018-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
amp:UnaffiliatedMember
2018-07-01
2018-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
amp:UnaffiliatedMember
2017-01-01
2017-09-30
0000727892
amp:OtherRevenueOtherFeesMember
2017-07-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
2017-01-01
2017-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
srt:AffiliatedEntityMember
2017-07-01
2017-09-30
0000727892
amp:OtherRevenueOtherFeesMember
srt:AffiliatedEntityMember
2017-01-01
2017-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
amp:UnaffiliatedMember
2017-01-01
2017-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
amp:UnaffiliatedMember
2018-07-01
2018-09-30
0000727892
amp:InsuranceCommissionsandFeesMember
amp:UnaffiliatedMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
srt:AffiliatedEntityMember
2018-01-01
2018-09-30
0000727892
amp:OtherRevenueAdministrativeFeesMember
amp:UnaffiliatedMember
2017-07-01
2017-09-30
0000727892
us-gaap:FixedMaturitiesMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2018-01-01
2018-09-30
0000727892
amp:RiverSourceTaxAdvantagedInvestmentsIncMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2017-12-31
0000727892
amp:RiverSourceTaxAdvantagedInvestmentsIncMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2018-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-09-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-09-30
0000727892
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:ForeignGovernmentDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-12-31
0000727892
us-gaap:EquitySecuritiesMember
2017-12-31
0000727892
us-gaap:USStatesAndPoliticalSubdivisionsMember
2017-12-31
0000727892
us-gaap:CorporateDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:FixedMaturitiesMember
2018-09-30
0000727892
us-gaap:USTreasuryAndGovernmentMember
2018-09-30
0000727892
2017-06-30
0000727892
2018-06-30
0000727892
us-gaap:FixedMaturitiesMember
2018-01-01
2018-09-30
0000727892
us-gaap:FixedMaturitiesMember
2017-01-01
2017-09-30
0000727892
us-gaap:FixedMaturitiesMember
2017-07-01
2017-09-30
0000727892
us-gaap:MortgagesMember
2018-07-01
2018-09-30
0000727892
us-gaap:MortgagesMember
2017-01-01
2017-09-30
0000727892
us-gaap:MortgagesMember
2018-01-01
2018-09-30
0000727892
us-gaap:OtherInvestmentsMember
2017-07-01
2017-09-30
0000727892
us-gaap:OtherInvestmentsMember
2018-07-01
2018-09-30
0000727892
us-gaap:OtherInvestmentsMember
2017-01-01
2017-09-30
0000727892
us-gaap:FixedMaturitiesMember
2018-07-01
2018-09-30
0000727892
us-gaap:MortgagesMember
2017-07-01
2017-09-30
0000727892
us-gaap:OtherInvestmentsMember
2018-01-01
2018-09-30
0000727892
amp:CreditRatingAMember
2018-09-30
0000727892
us-gaap:FixedMaturitiesMember
2017-12-31
0000727892
amp:CreditRatingAAMember
2017-12-31
0000727892
amp:CreditRatingAAAMember
2017-12-31
0000727892
amp:CreditRatingBelowInvestmentGradeMember
2017-12-31
0000727892
amp:CreditRatingBBBMember
2018-09-30
0000727892
amp:CreditRatingBBBMember
2017-12-31
0000727892
amp:CreditRatingAMember
2017-12-31
0000727892
amp:CreditRatingAAAMember
2018-09-30
0000727892
amp:CreditRatingBelowInvestmentGradeMember
2018-09-30
0000727892
amp:CreditRatingAAMember
2018-09-30
0000727892
us-gaap:USTreasuryAndGovernmentMember
2017-12-31
0000727892
amp:WestSouthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:WestSouthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:EastNorthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:EastNorthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:MiddleAtlanticMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:NewEnglandMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:SouthAtlanticMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:WestNorthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:MiddleAtlanticMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:MountainMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:MountainMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:EastSouthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:NewEnglandMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:SouthAtlanticMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:PacificMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:WestNorthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:EastSouthCentralMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:PacificMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
amp:MixedUseMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
srt:IndustrialPropertyMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
srt:HotelMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:MixedUseMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:RetailSiteMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:OtherPropertyMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:IndustrialPropertyMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:ApartmentBuildingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
srt:OfficeBuildingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:HotelMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:ApartmentBuildingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-09-30
0000727892
srt:OfficeBuildingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
srt:OtherPropertyMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
srt:RetailSiteMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2017-12-31
0000727892
amp:SyndicatedLoansMember
2017-01-01
2017-09-30
0000727892
amp:SyndicatedLoansMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2017-12-31
0000727892
amp:SyndicatedLoansMember
2018-01-01
2018-09-30
0000727892
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2017-12-31
0000727892
amp:SyndicatedLoansMember
2018-07-01
2018-09-30
0000727892
amp:SyndicatedLoansMember
2018-09-30
0000727892
amp:SyndicatedLoansMember
2017-07-01
2017-09-30
0000727892
amp:SyndicatedLoansMember
2017-12-31
0000727892
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2018-09-30
0000727892
amp:SyndicatedLoansMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2018-09-30
0000727892
amp:VULULandotherlifeinsuranceadditionalliabilitiesMember
2017-12-31
0000727892
amp:OtherLifeInsuranceMember
2017-12-31
0000727892
us-gaap:VariableAnnuityMember
2018-09-30
0000727892
amp:VariableUniversalLifeAndUniversalLifeInsuranceMember
2017-12-31
0000727892
us-gaap:VariableAnnuityMember
2017-12-31
0000727892
amp:IndexedUniversalLifeMember
2017-12-31
0000727892
amp:OtherVariableAnnuityGuaranteesMember
2017-12-31
0000727892
amp:VULULandotherlifeinsuranceadditionalliabilitiesMember
2018-09-30
0000727892
amp:LongtermcareinsuranceMember
2017-12-31
0000727892
amp:IndexedUniversalLifeMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-12-31
0000727892
amp:LifeandDisabilityIncomeInsuranceMember
2018-09-30
0000727892
amp:OtherLifeInsuranceMember
2018-09-30
0000727892
us-gaap:FixedAnnuityMember
2018-09-30
0000727892
amp:OtherVariableAnnuityGuaranteesMember
2018-09-30
0000727892
us-gaap:FixedAnnuityMember
2017-12-31
0000727892
amp:LongtermcareinsuranceMember
2018-09-30
0000727892
amp:LifeandDisabilityIncomeInsuranceMember
2017-12-31
0000727892
amp:FixedannuitieslifecontingentliabilitiesMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2017-12-31
0000727892
amp:FixedannuitieslifecontingentliabilitiesMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-09-30
0000727892
amp:VariableUniversalLifeAndUniversalLifeInsuranceMember
2018-09-30
0000727892
us-gaap:EquityFundsMember
2017-12-31
0000727892
us-gaap:FixedIncomeFundsMember
2018-09-30
0000727892
amp:OtherMutualFundsMember
2018-09-30
0000727892
us-gaap:MutualFundMember
2018-09-30
0000727892
us-gaap:EquityFundsMember
2018-09-30
0000727892
us-gaap:MutualFundMember
2017-12-31
0000727892
us-gaap:FixedIncomeFundsMember
2017-12-31
0000727892
amp:OtherMutualFundsMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-12-31
0000727892
us-gaap:GuaranteedLifetimeWithdrawalBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumWithdrawalStandardBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2017-01-01
2017-12-31
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitOtherMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitGainGrossUpMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2018-09-30
0000727892
us-gaap:GuaranteedLifetimeWithdrawalBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitOtherMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitOtherMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedLifetimeWithdrawalBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedLifetimeWithdrawalBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumWithdrawalStandardBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumWithdrawalStandardBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitGainGrossUpMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-01-01
2017-12-31
0000727892
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-01-01
2017-12-31
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-12-31
0000727892
amp:GuaranteedMinimumWithdrawalStandardBenefitMember
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-01-01
2017-12-31
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitGainGrossUpMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitOtherMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember
us-gaap:GuaranteedMinimumDeathBenefitMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitGainGrossUpMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedMinimumDeathBenefitMember
2017-01-01
2017-12-31
0000727892
amp:ULSecondaryGuaranteesMember
2018-01-01
2018-09-30
0000727892
amp:ULSecondaryGuaranteesMember
2018-09-30
0000727892
amp:ULSecondaryGuaranteesMember
2017-12-31
0000727892
amp:ULSecondaryGuaranteesMember
2017-01-01
2017-12-31
0000727892
amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember
2016-12-31
0000727892
amp:GuaranteedMinimumUniversalLifeMember
2018-09-30
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2016-12-31
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2017-01-01
2017-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember
2018-01-01
2018-09-30
0000727892
amp:GuaranteedMinimumUniversalLifeMember
2018-01-01
2018-09-30
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-09-30
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2017-01-01
2017-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumIncomeBenefitMember
2017-09-30
0000727892
amp:GuaranteedMinimumUniversalLifeMember
2017-01-01
2017-09-30
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2017-01-01
2017-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember
2017-01-01
2017-09-30
0000727892
amp:GuaranteedMinimumUniversalLifeMember
2017-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember
2018-09-30
0000727892
amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember
2017-09-30
0000727892
us-gaap:GuaranteedMinimumWithdrawalBenefitMember
2016-12-31
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2017-09-30
0000727892
amp:GuaranteedMinimumUniversalLifeMember
2016-12-31
0000727892
amp:GuaranteedMinimumUniversalLifeMember
2017-12-31
0000727892
us-gaap:GuaranteedMinimumAccumulationBenefitMember
2016-12-31
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2017-12-31
0000727892
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2018-01-01
2018-09-30
0000727892
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2017-12-31
0000727892
us-gaap:FederalHomeLoanBankAdvancesMember
2017-12-31
0000727892
us-gaap:FederalHomeLoanBankAdvancesMember
2017-01-01
2017-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FederalHomeLoanBankAdvancesMember
2017-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2017-12-31
0000727892
us-gaap:FederalHomeLoanBankAdvancesMember
2018-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FederalHomeLoanBankAdvancesMember
2018-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2018-09-30
0000727892
us-gaap:FederalHomeLoanBankAdvancesMember
2018-01-01
2018-09-30
0000727892
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2018-09-30
0000727892
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2017-01-01
2017-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:CreditRiskContractMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:EquityContractMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:InterestRateContractMember
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
amp:MeasurementInputYieldandSpreadtoTreasuryMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:IndexedAnnuitiesEmbeddedDerivativesMember
amp:MeasurementInputSurrenderRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
amp:MeasurementInputYieldandSpreadtoTreasuryMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputSurrenderRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
amp:MeasurementInputYieldandSpreadtoTreasuryMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:IndexedAnnuitiesEmbeddedDerivativesMember
amp:MeasurementInputSurrenderRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputSurrenderRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-07-01
2017-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-07-01
2017-09-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2017-07-01
2017-09-30
0000727892
us-gaap:EquitySecuritiesMember
2017-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-06-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2017-07-01
2017-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-06-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-09-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2017-06-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2017-09-30
0000727892
us-gaap:EquitySecuritiesMember
2017-07-01
2017-09-30
0000727892
us-gaap:EquitySecuritiesMember
2017-06-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-07-01
2017-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-06-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2017-09-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2017-06-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2018-07-01
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2018-07-01
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2018-07-01
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2018-06-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2018-09-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2018-07-01
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2018-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2018-06-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2018-09-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2018-06-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2018-06-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-01-01
2018-09-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-09-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2018-01-01
2018-09-30
0000727892
us-gaap:OtherContractMember
2018-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:OtherContractMember
2018-01-01
2018-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:CorporateDebtSecuritiesMember
2017-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-01-01
2018-09-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2017-12-31
0000727892
us-gaap:CorporateDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-01-01
2018-09-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2018-09-30
0000727892
us-gaap:OtherContractMember
2017-12-31
0000727892
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2017-12-31
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputSurrenderRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputSurrenderRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
amp:MeasurementInputYieldandSpreadtoTreasuryMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
amp:MeasurementInputYieldandSpreadtoTreasuryMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
amp:MeasurementInputYieldandSpreadtoTreasuryMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2017-01-01
2017-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2017-01-01
2017-09-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2017-01-01
2017-09-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2017-01-01
2017-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2016-12-31
0000727892
us-gaap:EquitySecuritiesMember
2017-01-01
2017-09-30
0000727892
us-gaap:EquitySecuritiesMember
2016-12-31
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2016-12-31
0000727892
us-gaap:CorporateDebtSecuritiesMember
2016-12-31
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2016-12-31
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2016-12-31
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2017-01-01
2017-09-30
0000727892
2017-01-01
2017-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2018-09-30
0000727892
amp:RiverSourceTaxAdvantagedInvestmentsIncMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2017-12-31
0000727892
amp:RiverSourceTaxAdvantagedInvestmentsIncMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CorporateDebtSecuritiesMember
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2018-01-01
2018-09-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2018-01-01
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2018-01-01
2018-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2018-01-01
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2017-12-31
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2017-12-31
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2017-12-31
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2017-07-01
2017-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2017-07-01
2017-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2017-06-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2017-06-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2017-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2017-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-07-01
2017-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-06-30
0000727892
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-07-01
2018-09-30
0000727892
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-06-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2018-06-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-07-01
2018-09-30
0000727892
us-gaap:OtherContractMember
2018-06-30
0000727892
us-gaap:AvailableforsaleSecuritiesMember
2018-07-01
2018-09-30
0000727892
us-gaap:OtherContractMember
2018-07-01
2018-09-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-06-30
0000727892
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-07-01
2018-09-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2018-07-01
2018-09-30
0000727892
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2018-06-30
0000727892
us-gaap:CorporateDebtSecuritiesMember
2018-06-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2016-12-31
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2017-01-01
2017-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2016-12-31
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-01-01
2017-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
2017-01-01
2017-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2016-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:FairValueInputsLevel3Member
amp:IndexedUniversalLifeEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
amp:GMWBAndGMABEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2017-12-31
0000727892
us-gaap:FairValueInputsLevel3Member
amp:IndexedAnnuitiesEmbeddedDerivativesMember
us-gaap:MeasurementInputCounterpartyCreditRiskMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2018-09-30
0000727892
us-gaap:ExchangeClearedMember
2017-12-31
0000727892
us-gaap:OverTheCounterMember
2017-12-31
0000727892
us-gaap:ExchangeTradedMember
2017-12-31
0000727892
amp:TotalOvertheCounterDerivativesMember
2018-09-30
0000727892
us-gaap:OverTheCounterMember
2018-09-30
0000727892
us-gaap:ExchangeClearedMember
2018-09-30
0000727892
us-gaap:ExchangeTradedMember
2018-09-30
0000727892
amp:TotalOvertheCounterDerivativesMember
2017-12-31
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:InterestCreditedToFixedAccountsMember
2018-07-01
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
amp:InterestCreditedToFixedAccountsMember
2018-07-01
2018-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
amp:InterestCreditedToFixedAccountsMember
2018-07-01
2018-09-30
0000727892
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-07-01
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
amp:InterestCreditedToFixedAccountsMember
2017-01-01
2017-09-30
0000727892
amp:InterestCreditedToFixedAccountsMember
2017-01-01
2017-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:InterestCreditedToFixedAccountsMember
2017-01-01
2017-09-30
0000727892
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-01-01
2017-09-30
0000727892
amp:DueAfterFourYearsMember
2018-09-30
0000727892
amp:DueInOneYearMember
2018-09-30
0000727892
amp:CurrentYearMember
2018-09-30
0000727892
amp:DueInTwoYearsMember
2018-09-30
0000727892
amp:DueInThreeYearsMember
2018-09-30
0000727892
amp:DueInFourYearsMember
2018-09-30
0000727892
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
amp:InterestCreditedToFixedAccountsMember
2018-01-01
2018-09-30
0000727892
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:InterestCreditedToFixedAccountsMember
2018-01-01
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
amp:InterestCreditedToFixedAccountsMember
2018-01-01
2018-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2018-01-01
2018-09-30
0000727892
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
amp:GMWBAndGMABEmbeddedDerivativesMember
2018-09-30
0000727892
us-gaap:OtherAssetsMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherAssetsMember
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2018-09-30
0000727892
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:OtherAssetsMember
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:OtherAssetsMember
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
amp:GMWBAndGMABEmbeddedDerivativesMember
2017-12-31
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
2017-12-31
0000727892
us-gaap:OtherAssetsMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
amp:IndexedUniversalLifeEmbeddedDerivativesMember
2017-12-31
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherAssetsMember
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherAssetsMember
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:OtherAssetsMember
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2018-09-30
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember
amp:IndexedAnnuitiesEmbeddedDerivativesMember
2017-12-31
0000727892
us-gaap:OtherAssetsMember
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:OtherAssetsMember
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:OtherLiabilitiesMember
us-gaap:NondesignatedMember
2017-12-31
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2018-09-30
0000727892
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
amp:IndexedUniversalLifeEmbeddedDerivativesMember
amp:InterestCreditedToFixedAccountsMember
2017-07-01
2017-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:InterestCreditedToFixedAccountsMember
2017-07-01
2017-09-30
0000727892
amp:InterestCreditedToFixedAccountsMember
2017-07-01
2017-09-30
0000727892
us-gaap:OtherContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
amp:GMWBAndGMABEmbeddedDerivativesMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
amp:BenefitsClaimsLossesAndSettlementExpensesMember
2017-07-01
2017-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-09-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-01-01
2018-09-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2017-12-31
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-01-01
2018-09-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2018-01-01
2018-09-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2017-12-31
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-12-31
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2018-09-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-06-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-07-01
2018-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-07-01
2018-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-06-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2018-06-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2018-07-01
2018-09-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2017-09-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2017-01-01
2017-09-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-01-01
2017-09-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2017-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2016-12-31
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2017-01-01
2017-09-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2016-12-31
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2016-12-31
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-07-01
2017-09-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2017-06-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2017-07-01
2017-09-30
0000727892
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-06-30
0000727892
amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember
2017-07-01
2017-09-30
0000727892
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2017-06-30
0000727892
amp:IncomeTaxProvisionMember
2017-01-01
2017-09-30
0000727892
us-gaap:StateAndLocalJurisdictionMember
2018-09-30
0000727892
us-gaap:InsuranceRelatedAssessmentsMember
2018-09-30
0000727892
us-gaap:InsuranceRelatedAssessmentsMember
2017-01-01
2017-12-31
0000727892
us-gaap:InsuranceRelatedAssessmentsMember
2018-01-01
2018-09-30
0000727892
us-gaap:InsuranceRelatedAssessmentsMember
2017-12-31
iso4217:USD
xbrli:shares
amp:item
xbrli:shares
xbrli:pure
iso4217:USD
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
| |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended September 30, 2018
OR
| |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Transition Period from_______________________to_______________________
Commission File No. 033-28976
RIVERSOURCE LIFE INSURANCE COMPANY
(Exact name of registrant as specified in its charter)
|
| | |
Minnesota | | 41-0823832 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
1099 Ameriprise Financial Center, Minneapolis, Minnesota | | 55474 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (612) 671-3131
Former name, former address and former fiscal year, if changed since last report: Not Applicable
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
|
| | |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. |
Large Accelerated Filer o | Accelerated Filer o |
Non-Accelerated Filer x
| Smaller reporting company o |
Emerging growth company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. |
| | |
Class | | Outstanding at November 5, 2018 |
Common Stock (par value $30 per share) | | 100,000 Shares |
THE REGISTRANT MEETS THE CONDITIONS SET FORTH IN GENERAL INSTRUCTIONS H(1) (a) AND (b) OF FORM 10-Q AND IS THEREFORE FILING THIS FORM WITH THE REDUCED DISCLOSURE FORMAT.
RIVERSOURCE LIFE INSURANCE COMPANY
FORM 10-Q
INDEX
|
| | | | | |
Part I. Financial Information | |
Item 1. Financial Statements (Unaudited) | |
Consolidated Balance Sheets — September 30, 2018 and December 31, 2017 | |
Consolidated Statements of Income — Three months and nine months ended September 30, 2018 and 2017 | |
Consolidated Statements of Comprehensive Income — Three months and nine months ended September 30, 2018 and 2017 | |
Consolidated Statements of Shareholder’s Equity — Nine months ended September 30, 2018 and 2017 | |
Consolidated Statements of Cash Flows — Nine months ended September 30, 2018 and 2017 | |
Notes to Consolidated Financial Statements | |
1. Basis of Presentation | |
2. Recent Accounting Pronouncements | |
3. Revenue from Contracts with Customers | |
4. Variable Interest Entities | |
5. Investments | |
6. Financing Receivables | |
7. Deferred Acquisition Costs and Deferred Sales Inducement Costs | |
8. Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | |
9. Variable Annuity and Insurance Guarantees | |
10. Short-term Borrowings | |
11. Fair Values of Assets and Liabilities | |
12. Regulatory Requirements | |
13. Offsetting Assets and Liabilities | |
14. Derivatives and Hedging Activities | |
15. Shareholder’s Equity | |
16. Income Taxes | |
17. Contingencies | |
Item 2. Management’s Narrative Analysis | |
Item 4. Controls and Procedures | |
| |
Part II. Other Information | |
Item 1. Legal Proceedings | |
Item 1A. Risk Factors | |
Item 6. Exhibits | |
Signatures | |
RIVERSOURCE LIFE INSURANCE COMPANY
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
|
| | | | | | | |
| September 30, 2018 | | December 31, 2017 |
(in millions, except share amounts) |
Assets | | | |
Investments: | | | |
Available-for-Sale: Fixed maturities, at fair value (amortized cost: 2018, $20,928; 2017, $20,764) | $ | 21,472 |
| | $ | 22,155 |
|
Mortgage loans, at amortized cost (less allowance for loan losses: 2018 and 2017, $16) | 2,540 |
| | 2,619 |
|
Policy loans | 854 |
| | 845 |
|
Other investments | 848 |
| | 900 |
|
Total investments | 25,714 |
| | 26,519 |
|
Cash and cash equivalents | 675 |
| | 1,062 |
|
Reinsurance recoverables | 3,068 |
| | 2,876 |
|
Other receivables | 202 |
| | 207 |
|
Accrued investment income | 214 |
| | 219 |
|
Deferred acquisition costs | 2,793 |
| | 2,639 |
|
Other assets | 4,252 |
| | 4,358 |
|
Separate account assets | 81,688 |
| | 82,560 |
|
Total assets | $ | 118,606 |
| | $ | 120,440 |
|
| | | |
Liabilities and Shareholder’s Equity | | | |
Liabilities: | | | |
Policyholder account balances, future policy benefits and claims | $ | 28,476 |
| | $ | 29,178 |
|
Short-term borrowings | 201 |
| | 200 |
|
Other liabilities | 4,702 |
| | 4,674 |
|
Separate account liabilities | 81,688 |
| | 82,560 |
|
Total liabilities | 115,067 |
| | 116,612 |
|
| | | |
Shareholder’s equity: | | | |
Common stock, $30 par value; 100,000 shares authorized, issued and outstanding | 3 |
| | 3 |
|
Additional paid-in capital | 2,466 |
| | 2,466 |
|
Retained earnings | 1,005 |
| | 903 |
|
Accumulated other comprehensive income, net of tax | 65 |
| | 456 |
|
Total shareholder’s equity | 3,539 |
| | 3,828 |
|
Total liabilities and shareholder’s equity | $ | 118,606 |
| | $ | 120,440 |
|
See Notes to Consolidated Financial Statements.
RIVERSOURCE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
|
| | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
2018 | | 2017 (1) | 2018 | | 2017 (1) |
(in millions) |
Revenues | | | | | | | |
Premiums | $ | 101 |
| | $ | 99 |
| | $ | 296 |
| | $ | 304 |
|
Net investment income | 243 |
| | 261 |
| | 757 |
| | 797 |
|
Policy and contract charges | 576 |
| | 448 |
| | 1,579 |
| | 1,427 |
|
Other revenues | 104 |
| | 99 |
| | 313 |
| | 296 |
|
Net realized investment gains (losses) | 4 |
| | — |
| | 14 |
| | 31 |
|
Total revenues | 1,028 |
| | 907 |
| | 2,959 |
| | 2,855 |
|
Benefits and expenses | | | | | | | |
Benefits, claims, losses and settlement expenses | 480 |
| | 236 |
| | 1,134 |
| | 920 |
|
Interest credited to fixed accounts | 178 |
| | 176 |
| | 499 |
| | 509 |
|
Amortization of deferred acquisition costs | 11 |
| | 32 |
| | 133 |
| | 142 |
|
Other insurance and operating expenses | 168 |
| | 176 |
| | 512 |
| | 527 |
|
Total benefits and expenses | 837 |
| | 620 |
| | 2,278 |
| | 2,098 |
|
Pretax income (loss) | 191 |
| | 287 |
| | 681 |
| | 757 |
|
Income tax provision (benefit) | (8 | ) | | 34 |
| | 29 |
| | 71 |
|
Net income | $ | 199 |
| | $ | 253 |
| | $ | 652 |
| | $ | 686 |
|
| | | | | | | |
Supplemental Disclosures: | | | | | | | |
Total other-than-temporary impairment losses on securities | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
|
Portion of loss recognized in other comprehensive income (before taxes) | — |
| | — |
| | — |
| | — |
|
Net impairment losses recognized in net realized investment gains (losses) | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
|
(1)
See Notes to Consolidated Financial Statements.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
|
| | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
2018 | | 2017 | | 2018 | | 2017 |
(in millions) |
Net income | $ | 199 |
| | $ | 253 |
| | $ | 652 |
| | $ | 686 |
|
Other comprehensive income (loss), net of tax: | | | | | | | |
Net unrealized gains (losses) on securities | (51 | ) | | (7 | ) | | (392 | ) | | 29 |
|
Net unrealized gains (losses) on derivatives | — |
| | 1 |
| | 1 |
| | 3 |
|
Other | — |
| | — |
| | — |
| | (1 | ) |
Total other comprehensive income (loss), net of tax | (51 | ) | | (6 | ) | | (391 | ) | | 31 |
|
Total comprehensive income | $ | 148 |
| | $ | 247 |
| | $ | 261 |
| | $ | 717 |
|
See Notes to Consolidated Financial Statements.
RIVERSOURCE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF SHAREHOLDER’S EQUITY (UNAUDITED)
|
| | | | | | | | | | | | | | | | | | | |
| Common Shares | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Total |
(in millions) |
Balances at January 1, 2017 | $ | 3 |
| | $ | 2,466 |
| | $ | 862 |
| | $ | 457 |
| | $ | 3,788 |
|
Comprehensive income: | | | | | | | | | |
Net income | — |
| | — |
| | 686 |
| | — |
| | 686 |
|
Other comprehensive income (loss), net of tax | — |
| | — |
| | — |
| | 31 |
| | 31 |
|
Total comprehensive income | | 717 |
|
Cash dividends to Ameriprise Financial, Inc. | — |
| | — |
| | (700 | ) | | — |
| | (700 | ) |
Balances at September 30, 2017 | $ | 3 |
| | $ | 2,466 |
| | $ | 848 |
| | $ | 488 |
| | $ | 3,805 |
|
| | | | | | | | | |
Balances at January 1, 2018 | $ | 3 |
| | $ | 2,466 |
| | $ | 903 |
| | $ | 456 |
| | $ | 3,828 |
|
Comprehensive income: | | | | | | | | | |
Net income | — |
| | — |
| | 652 |
| | — |
| | 652 |
|
Other comprehensive income (loss), net of tax | — |
| | — |
| | — |
| | (391 | ) | | (391 | ) |
Total comprehensive income | | 261 |
|
Cash dividends to Ameriprise Financial, Inc. | — |
| | — |
| | (550 | ) | | — |
| | (550 | ) |
Balances at September 30, 2018 | $ | 3 |
| | $ | 2,466 |
| | $ | 1,005 |
| | $ | 65 |
| | $ | 3,539 |
|
See Notes to Consolidated Financial Statements.
RIVERSOURCE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
|
| | | | | | | | |
| | Nine Months Ended September 30, |
| 2018 | | 2017 |
| (in millions) |
| Cash Flows from Operating Activities | | | |
| Net income | $ | 652 |
| | $ | 686 |
|
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |
| | |
|
| Depreciation, amortization and accretion, net | 31 |
| | 36 |
|
| Deferred income tax (benefit) expense | (25 | ) | | (71 | ) |
| Contractholder and policyholder charges, non-cash | (274 | ) | | (268 | ) |
| Loss from equity method investments | 50 |
| | 44 |
|
| Net realized investment (gains) losses | (14 | ) | | (31 | ) |
| Changes in operating assets and liabilities: | |
| | |
|
| Deferred acquisition costs | (59 | ) | | (31 | ) |
| Policyholder account balances, future policy benefits and claims, net | (251 | ) | | (118 | ) |
| Derivatives, net of collateral | 327 |
| | 500 |
|
| Reinsurance recoverables | (168 | ) | | (235 | ) |
| Other receivables | 8 |
| | 50 |
|
| Accrued investment income | 5 |
| | 16 |
|
| Other, net | 31 |
| | (55 | ) |
| Net cash provided by (used in) operating activities | 313 |
| | 523 |
|
| | | | |
| Cash Flows from Investing Activities | | | |
| Available-for-Sale securities: | | | |
| Proceeds from sales | 40 |
| | 209 |
|
| Maturities, sinking fund payments and calls | 2,102 |
| | 1,843 |
|
| Purchases | (2,327 | ) | | (1,315 | ) |
| Proceeds from sales, maturities and repayments of mortgage loans | 222 |
| | 341 |
|
| Funding of mortgage loans | (143 | ) | | (352 | ) |
| Proceeds from sales and collections of other investments | 112 |
| | 126 |
|
| Purchase of other investments | (168 | ) | | (154 | ) |
| Purchase of land, buildings, equipment and software | (6 | ) | | (7 | ) |
| Change in policy loans, net | (9 | ) | | (11 | ) |
| Advance on line of credit to Ameriprise Financial, Inc. | (65 | ) | | — |
|
| Repayment from Ameriprise Financial, Inc. on line of credit | 65 |
| | — |
|
| Other, net | 15 |
| | 31 |
|
| Net cash provided by (used in) investing activities | (162 | ) | | 711 |
|
| See Notes to Consolidated Financial Statements. |
|
RIVERSOURCE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (Continued)
|
| | | | | | | |
| Nine Months Ended September 30, |
2018 | | 2017 |
(in millions) |
Cash Flows from Financing Activities | | | |
Policyholder account balances: | | | |
Deposits and other additions | $ | 1,511 |
| | $ | 1,538 |
|
Net transfers from (to) separate accounts | (89 | ) | | (120 | ) |
Surrenders and other benefits | (1,406 | ) | | (1,413 | ) |
Proceeds from line of credit with Ameriprise Financial, Inc. | 10 |
| | 5 |
|
Payments on line of credit with Ameriprise Financial, Inc. | (10 | ) | | (5 | ) |
Cash received for purchased options with deferred premiums | 161 |
| | 43 |
|
Cash paid for purchased options with deferred premiums | (165 | ) | | (171 | ) |
Cash dividends to Ameriprise Financial, Inc. | (550 | ) | | (700 | ) |
Net cash provided by (used in) financing activities | (538 | ) | | (823 | ) |
Net increase (decrease) in cash and cash equivalents | (387 | ) | | 411 |
|
Cash and cash equivalents at beginning of period | 1,062 |
| | 323 |
|
Cash and cash equivalents at end of period | $ | 675 |
| | $ | 734 |
|
| | | |
Supplemental Disclosures: | | | |
Income taxes paid (received), net | $ | 93 |
| | $ | 243 |
|
Interest paid on borrowings | 3 |
| | 1 |
|
Non-cash investing activity: | |
| | |
|
Partnership commitments not yet remitted | 1 |
| | 9 |
|
See Notes to Consolidated Financial Statements. |
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. Basis of Presentation
RiverSource Life Insurance Company is a stock life insurance company with one wholly owned stock life insurance company subsidiary, RiverSource Life Insurance Co. of New York (“RiverSource Life of NY”). RiverSource Life Insurance Company is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”).
| |
• | RiverSource Life Insurance Company is domiciled in Minnesota and holds Certificates of Authority in American Samoa, the District of Columbia and all states except New York. RiverSource Life Insurance Company issues insurance and annuity products. |
| |
• | RiverSource Life of NY is domiciled and holds a Certificate of Authority in New York. RiverSource Life of NY issues insurance and annuity products. |
RiverSource Life Insurance Company also wholly owns RiverSource Tax Advantaged Investments, Inc. (“RTA”). RTA is a stock company domiciled in Delaware and is a limited partner in affordable housing partnership investments.
The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation.
The interim financial information in this report has not been audited. In the opinion of management, all adjustments necessary for fair statement of the consolidated financial position and results of operations for the interim periods have been made. Except for the out-of-period correction described below and the prior period adjustments for the retrospective adoption of the new revenue recognition accounting standard, all adjustments made were of a normal recurring nature.
In the first quarter of 2017, the Company recorded a $20 million decrease to income tax provision related to an out-of-period correction for a reversal of a tax reserve.
The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. These Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission on February 22, 2018 (“2017 10-K”).
The Company evaluated events or transactions that may have occurred after the balance sheet date for potential recognition or disclosure through the date the financial statements were issued. No subsequent events or transactions were identified.
On January 1, 2018, the Company retrospectively adopted the new accounting standard for revenue recognition. See Note 2 and Note 3 for further information on the new accounting standard and the Company’s revenue from contracts with customers. The impact to the consolidated statements of income for the three months and nine months ended September 30, 2017 was an increase of $4 million and $12 million, respectively, to policy and contract charges, and a decrease of $4 million and $12 million, respectively, to other revenues.
2. Recent Accounting Pronouncements
Adoption of New Accounting Standards
Revenue from Contracts with Customers
In May 2014, the Financial Accounting Standards Board (“FASB”) updated the accounting standards for revenue from contracts with customers. The update provides a five step revenue recognition model for all revenue arising from contracts with customers and affects all entities that enter into contracts to provide goods or services to their customers (unless the contracts are in the scope of other standards). The standard also updates the accounting for certain costs associated with obtaining and fulfilling a customer contract and requires disclosure of quantitative and qualitative information that enables users of financial statements to understand the nature, amount, timing, and uncertainty of revenues and cash flows arising from contracts with customers. The standard is effective for interim and annual periods beginning after December 15, 2017. The standard may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The Company adopted the revenue recognition guidance on a retrospective basis on January 1, 2018. The update does not apply to revenue associated with the manufacturing of insurance and annuity products or financial instruments as these revenues are in the scope of other standards. Therefore, the update did not have an impact on these revenues. The Company’s implementation efforts included the identification of revenue within the guidance and the review of the customer contracts to determine the Company’s performance obligation and the associated timing of each performance obligation. The adoption of the standard resulted in the reclassification of certain revenues within total revenues. See Note 3 for new disclosures on revenue from contracts with customers.
Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities
In January 2016, the FASB updated the accounting standards on the recognition and measurement of financial instruments. The update requires entities to carry marketable equity securities, excluding investments in securities that qualify for the equity method of
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
accounting, at fair value with changes in fair value reflected in net income each reporting period. The update affects other aspects of accounting for equity instruments, as well as the accounting for financial liabilities utilizing the fair value option. The update eliminates the requirement to disclose the methods and assumptions used to estimate the fair value of financial assets or liabilities held at cost on the balance sheet and requires entities to use the exit price notion when measuring the fair value of these financial instruments. The standard is effective for interim and annual periods beginning after December 15, 2017. The Company adopted the standard on January 1, 2018 using a modified retrospective approach. The adoption of the standard did not have a material impact on the Company’s consolidated financial condition or results of operations.
Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory
In October 2016, the FASB updated the accounting standards related to the recognition of income tax impacts on intra-entity transfers. The update requires entities to recognize the income tax consequences of intra-entity transfers, other than inventory, upon the transfer of the asset. The update requires the selling entity to recognize a current tax expense or benefit and the purchasing entity to recognize a deferred tax asset or liability when the transfer occurs. The standard is effective for interim and annual periods beginning after December 15, 2017. The Company adopted the standard on January 1, 2018. The adoption of the standard did not have an impact on the Company’s consolidated financial condition or results of operations.
Future Adoption of New Accounting Standards
Financial Services – Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts
In August 2018, the FASB updated the accounting standard related to long-duration insurance contracts. The guidance revises key elements of the measurement models and disclosure requirements for long-duration insurance contracts issued by insurers and reinsurers.
The guidance establishes a significant new category of benefit features called market risk benefits that protect the contract holder from other-than-nominal capital market risk and expose the insurer to that risk. Insurers will have to measure market risk benefits at fair value. Market risk benefits include variable annuity guaranteed benefits (i.e. guaranteed minimum death, withdrawal, withdrawal for life, accumulation and income benefits). The portion of the change in fair value attributable to a change in the instrument-specific credit risk of market risk benefits in a liability position will be recorded in other comprehensive income (“OCI”).
Significant changes also relate to the measurement of the liability for future policy benefits for nonparticipating traditional long-duration insurance contracts and immediate annuities with a life contingent feature include the following:
| |
• | Insurers will be required to review and update the cash flow assumptions used to measure the liability for future policy benefits rather than using assumptions locked in at contract inception. The review of assumptions to measure the liability for all future policy benefits will be required annually at the same time each year, or more frequently if suggested by experience. The effect of updating assumptions will be measured on a retrospective catch-up basis and presented separate from the ongoing policyholder benefit expense in the statement of operations in the period the update is made. This new unlocking process will be required for the Company’s term and whole life insurance, disability income, long term care insurance and immediate annuities with a life contingent feature. |
| |
• | The discount rate used to measure the liability for future policy benefits will be standardized. The current requirement to use a discount rate reflecting expected investment yields will change to an upper-medium grade (low credit risk) fixed income corporate instrument yield (generally interpreted as an “A” rating) reflecting the duration characteristics of the liability. Entities will be required to update the discount rate at each reporting date with the effect of discount rate changes reflected in OCI. |
| |
• | The current premium deficiency test is being replaced with a net premium ratio cap of 100%. If the net premium ratio (i.e. the ratio of the present value of total expected benefits and related expenses to the present value of total expected premiums) exceeds 100%, insurers are required to recognize a loss in the statement of operations in the period. Contracts from different issue years will no longer be permitted to be grouped to determine contracts in a loss position. |
In addition, the update requires deferred acquisition costs (“DAC”) and deferred sales inducement costs (“DSIC”) relating to all long-duration contracts and most investment contracts to be amortized on a straight-line basis over the expected life of the contract independent of profit emergence. Under the new guidance, interest will not accrue to the deferred balance and DAC and DSIC will not be subject to an impairment test.
The update requires significant additional disclosures, including disaggregated rollforwards of the liability for future policy benefits, policyholder account balances, market risk benefits, DAC and DSIC, as well as qualitative and quantitative information about expected cash flows, estimates and assumptions. The update is effective for interim and annual periods beginning after December 15, 2020. The standard should be applied to the liability for future policy benefits and DAC and DSIC on a modified retrospective basis and applied to market risk benefits on a retrospective basis with the option to apply full retrospective transition if certain criteria are met. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial condition, results of operations and disclosures.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Fair Value Measurement – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement
In August 2018, the FASB updated the accounting standards related to disclosures for fair value measurements. The update eliminates the following disclosures: 1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, 2) the policy of timing of transfers between levels of the fair value hierarchy, and 3) the valuation processes for Level 3 fair value measurements. The new disclosures include changes in unrealized gains and losses for the period included in OCI for recurring Level 3 fair value measurements of instruments held at the end of the reporting period and the range and weighted average used to develop significant unobservable inputs and how the weighted average was calculated. The new disclosures are required on a prospective basis; all other provisions should be applied retrospectively. The update is effective for interim and annual periods beginning after December 15, 2019. Early adoption is permitted for the entire standard or only the provisions that eliminate or modify disclosure requirements. The Company is currently evaluating the impact of the standard on its disclosures. The update does not have an impact on the Company’s consolidated financial condition or results of operations.
Intangibles – Goodwill and Other – Internal-Use Software – Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
In August 2018, the FASB updated the accounting standards related to customer’s accounting for implementation costs incurred in a cloud computing arrangement (“CCA”) that is a service contract. The update requires implementation costs for a CCA to be evaluated for capitalization using the same approach as implementation costs associated with internal-use software. The update also addresses presentation, measurement and impairment of capitalized implementation costs in a CCA that is a service contract. The update requires new disclosures on the nature of hosting arrangements that are service contracts, significant judgements made when applying the guidance and quantitative disclosures, including amounts capitalized, amortized and impaired. The update is effective for interim and annual periods beginning after December 15, 2019, and can be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial condition, results of operations and disclosures.
Income Statement – Reporting Comprehensive Income – Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
In February 2018, the FASB updated the accounting standards related to the presentation of tax effects stranded in OCI. The update allows a reclassification from accumulated other comprehensive income (“AOCI”) to retained earnings for tax effects stranded in AOCI resulting from the legislation commonly referred to as the Tax Cuts and Jobs Act (“Tax Act”). The update is optional and entities may elect not to reclassify the stranded tax effects. The update is effective for fiscal years beginning after December 15, 2018. Entities may elect to record the impacts either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. Early adoption is permitted in any period. The Company does not plan to reclassify the stranded tax effects in OCI. As such, the update will not have an impact on the Company’s consolidated financial condition and results of operations.
Derivatives and Hedging – Targeted Improvements to Accounting for Hedging Activities
In August 2017, the FASB updated the accounting standards to amend the hedge accounting recognition and presentation requirements. The objectives of the update are to better align the financial reporting of hedging relationships to the economic results of an entity’s risk management activities and simplify the application of the hedge accounting guidance. The update also adds new disclosures and amends existing disclosure requirements. The standard is effective for interim and annual periods beginning after December 15, 2018, and should be applied on a modified retrospective basis. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations.
Receivables - Nonrefundable Fees and Other Costs - Premium Amortization on Purchased Callable Debt Securities
In March 2017, the FASB updated the accounting standards to shorten the amortization period for certain purchased callable debt securities held at a premium. Under current guidance, premiums are generally amortized over the contractual life of the security. The amendments require the premium to be amortized to the earliest call date. The update applies to securities with explicit, non-contingent call features that are callable at fixed prices and on preset dates. The standard is effective for interim and annual periods beginning after December 15, 2018, and should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Early adoption is permitted. The update is not expected to have a material impact on the Company’s consolidated financial condition or results of operations.
Financial Instruments – Credit Losses – Measurement of Credit Losses on Financial Instruments
In June 2016, the FASB updated the accounting standards related to accounting for credit losses on certain types of financial instruments. The update replaces the current incurred loss model for estimating credit losses with a new model that requires an entity to estimate the credit losses expected over the life of the asset. Generally, the initial estimate of the expected credit losses and subsequent changes in the estimate will be reported in current period earnings and recorded through an allowance for credit losses on the balance sheet. The current credit loss model for Available-for-Sale debt securities does not change; however, the credit loss calculation and subsequent recoveries are required to be recorded through an allowance. The standard is effective for interim and annual periods beginning after December 15, 2019. Early adoption will be permitted for interim and annual periods beginning after
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
December 15, 2018. A modified retrospective cumulative adjustment to retained earnings should be recorded as of the first reporting period in which the guidance is effective for loans, receivables, and other financial instruments subject to the new expected credit loss model. Prospective adoption is required for establishing an allowance related to Available-for-Sale debt securities, certain beneficial interests, and financial assets purchased with a more-than-insignificant amount of credit deterioration since origination. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations.
Leases
In February 2016, the FASB updated the accounting standards for leases. The update was issued to increase transparency and comparability for the accounting of lease transactions. The standard will require most lease transactions for lessees to be recorded on the balance sheet as lease assets and lease liabilities and both quantitative and qualitative disclosures about leasing arrangements. The standard is effective for interim and annual periods beginning after December 15, 2018 with early adoption permitted. Entities may elect to adopt the standard using a modified retrospective approach at either the beginning of the earliest period presented or as of the date of adoption. The Company plans to adopt the standard using a modified retrospective approach as of the date of adoption and is currently evaluating the impact of the standard on its consolidated financial condition and results of operations.
3. Revenue from Contracts with Customers
On January 1, 2018, the Company adopted the new accounting standard for revenue from contracts with customers on a retrospective basis.
The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Consolidated Statements of Income. Revenues related to manufacturing of insurance and annuity products or financial instruments are not in the scope of this standard and are included in the table below under the heading Revenue from other sources. See Note 2 for additional information on the adoption of the new accounting standard.
|
| | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
2018 | | 2017 | | 2018 | | 2017 |
(in millions) |
Policy and contract charges | | | | | | | |
Affiliated | $ | 43 |
| | $ | 43 |
| | $ | 129 |
| | $ | 124 |
|
Unaffiliated | 4 |
| | 4 |
| | 12 |
| | 12 |
|
Total | 47 |
| | 47 |
| | 141 |
| | 136 |
|
| | | | | | | |
Other revenues | | | | | | | |
Administrative fees | | | | | | | |
Affiliated | 11 |
| | 10 |
| | 33 |
| | 31 |
|
Unaffiliated | 5 |
| | 6 |
| | 17 |
| | 17 |
|
| 16 |
| | 16 |
| | 50 |
| | 48 |
|
Other fees | | | | | | | |
Affiliated | 85 |
| | 82 |
| | 256 |
| | 242 |
|
Unaffiliated | 1 |
| | 1 |
| | 3 |
| | 3 |
|
| 86 |
| | 83 |
| | 259 |
| | 245 |
|
Total | 102 |
| | 99 |
| | 309 |
| | 293 |
|
Total revenue from contracts with customers | 149 |
| | 146 |
| | 450 |
| | 429 |
|
Revenue from other sources (1) | 879 |
| | 761 |
| | 2,509 |
| | 2,426 |
|
Total revenues | $ | 1,028 |
| | $ | 907 |
| | $ | 2,959 |
| | $ | 2,855 |
|
(1)
The following discussion describes the nature, timing, and uncertainty of revenues and cash flows arising from the Company’s contracts with customers.
Policy and contract charges
The Company earns revenue for providing distribution-related services to mutual funds that are available as underlying investments in its variable annuity and variable life insurance products. The performance obligation is satisfied at the time the mutual fund is distributed. Revenue is recognized over the time the mutual fund is held in the variable product and is generally earned based on a fixed rate applied, as a percentage, to the net asset value of the fund. The revenue is not recognized at the time of sale because it is
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
variably constrained due to factors outside the Company’s control, including market volatility and how long the fund(s) remain in the insurance policy or annuity contract. The revenue will not be recognized until it is probable that a significant reversal will not occur. These fees are accrued and collected on a monthly basis.
Other revenues
Administrative fees
The Company earns revenue for providing customer support, contract servicing and administrative services for affiliated and unaffiliated mutual funds. The transfer agent and administration revenue is earned daily based on a fixed rate applied, as a percentage, to assets under management. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.
Other fees
The Company earns revenue for providing affiliated and unaffiliated partners an opportunity to educate the financial advisors of its affiliate, Ameriprise Financial Services, Inc., that sell the Company's products as well as product and marketing personnel to support the offer, sale and servicing of funds within the Company's variable annuity and life products. These payments allow the parties to train and support the advisors, explain the features of their products, and distribute marketing and educational materials. The affiliated revenue is earned based on a rate, updated at least annually, which is applied, as a percentage, to the market value of assets invested. The unaffiliated revenue is earned based on a fixed rate applied, as a percentage, to the market value of assets invested. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.
Receivables
Receivables for revenue from contracts with customers are recognized when the performance obligation is satisfied and the Company has an unconditional right to the revenue. Receivables related to revenues from contracts with customers were $54 million as of both September 30, 2018 and December 31, 2017.
4. Variable Interest Entities
The Company is a limited partner in affordable housing partnerships that qualify for government-sponsored low income housing tax credit programs and partnerships that invest in multi-family residential properties that were originally developed with an affordable housing component. The Company has determined it is not the primary beneficiary and therefore does not consolidate these partnerships.
A majority of the limited partnerships are variable interest entities (“VIEs”). The Company’s maximum exposure to loss as a result of its investment in the VIEs is limited to the carrying value. The carrying value is reflected in other investments and was $364 million and $408 million as of September 30, 2018 and December 31, 2017, respectively. The Company had a $57 million and a $97 million liability recorded as of September 30, 2018 and December 31, 2017, respectively, related to original purchase commitments not yet remitted to the VIEs. The Company has not provided any additional support and is not contractually obligated to provide additional support to the VIEs beyond the above mentioned funding commitments.
The Company invests in structured investments which are considered VIEs for which it is not the sponsor. These structured investments typically invest in fixed income instruments and are managed by third parties and include asset backed securities, commercial mortgage backed securities and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the size of the Company’s investment in the entities and position in the capital structure of these entities. The Company’s maximum exposure to loss as a result of its investment in these structured investments is limited to its carrying value. The Company has no obligation to provide financial or other support to the structured investments beyond its investment nor has the Company provided any support to the structured investments. See Note 5 for additional information on these structured investments.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
5. Investments
Available-for-Sale securities distributed by type were as follows:
|
| | | | | | | | | | | | | | | | | | | | |
Description of Securities | | September 30, 2018 |
Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Noncredit OTTI (1) |
| | (in millions) |
Fixed maturities: | | |
| | |
| | |
| | |
| | |
|
Corporate debt securities | | $ | 12,147 |
| | $ | 658 |
| | $ | (126 | ) | | $ | 12,679 |
| | $ | — |
|
Residential mortgage backed securities | | 2,959 |
| | 19 |
| | (71 | ) | | 2,907 |
| | — |
|
Commercial mortgage backed securities | | 3,748 |
| | 15 |
| | (125 | ) | | 3,638 |
| | — |
|
State and municipal obligations | | 1,126 |
| | 157 |
| | (5 | ) | | 1,278 |
| | — |
|
Asset backed securities | | 651 |
| | 25 |
| | (5 | ) | | 671 |
| | — |
|
Foreign government bonds and obligations | | 296 |
| | 10 |
| | (8 | ) | | 298 |
| | — |
|
U.S. government and agency obligations | | 1 |
| | — |
| | — |
| | 1 |
| | — |
|
Total | | $ | 20,928 |
| | $ | 884 |
| | $ | (340 | ) | | $ | 21,472 |
| | $ | — |
|
|
| | | | | | | | | | | | | | | | | | | | |
Description of Securities | | December 31, 2017 |
Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Noncredit OTTI (1) |
| | (in millions) |
Fixed maturities: | | |
| | |
| | |
| | |
| | |
|
Corporate debt securities | | $ | 12,133 |
| | $ | 1,125 |
| | $ | (25 | ) | | $ | 13,233 |
| | $ | — |
|
Residential mortgage backed securities | | 2,979 |
| | 54 |
| | (22 | ) | | 3,011 |
| | — |
|
Commercial mortgage backed securities | | 3,554 |
| | 47 |
| | (32 | ) | | 3,569 |
| | — |
|
State and municipal obligations | | 1,114 |
| | 209 |
| | (9 | ) | | 1,314 |
| | — |
|
Asset backed securities | | 700 |
| | 30 |
| | (2 | ) | | 728 |
| | — |
|
Foreign government bonds and obligations | | 283 |
| | 20 |
| | (4 | ) | | 299 |
| | — |
|
U.S. government and agency obligations | | 1 |
| | — |
| | — |
| | 1 |
| | — |
|
Total fixed maturities | | 20,764 |
| | 1,485 |
| | (94 | ) | | 22,155 |
| | — |
|
Common stocks | | 1 |
| | — |
| | (1 | ) | | — |
| | — |
|
Total | | $ | 20,765 |
| | $ | 1,485 |
| | $ | (95 | ) | | $ | 22,155 |
| | $ | — |
|
As of September 30, 2018 and December 31, 2017, investment securities with a fair value of $1.8 billion and $1.6 billion, respectively, were pledged to meet contractual obligations under derivative contracts and short-term borrowings, of which $902 million and $711 million, respectively, may be sold, pledged or rehypothecated by the counterparty.
As of both September 30, 2018 and December 31, 2017, fixed maturity securities comprised approximately 84% of the Company’s total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of September 30, 2018 and December 31, 2017, approximately $773 million and $906 million, respectively, of securities were internally rated by Columbia Management Investment Advisers, LLC, an affiliate of the Company, using criteria similar to those used by NRSROs.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
A summary of fixed maturity securities by rating was as follows:
|
| | | | | | | | | | | | | | | | | | | | | | |
Ratings | | September 30, 2018 | | December 31, 2017 |
Amortized Cost | | Fair Value | | Percent of Total Fair Value | Amortized Cost | | Fair Value | | Percent of Total Fair Value |
| | (in millions, except percentages) | | |
AAA | | $ | 6,595 |
| | $ | 6,427 |
| | 30 | % | | $ | 6,259 |
| | $ | 6,303 |
| | 28 | % |
AA | | 1,002 |
| | 1,136 |
| | 5 |
| | 1,090 |
| | 1,285 |
| | 6 |
|
A | | 2,959 |
| | 3,195 |
| | 15 |
| | 3,443 |
| | 3,902 |
| | 18 |
|
BBB | | 9,461 |
| | 9,806 |
| | 46 |
| | 8,796 |
| | 9,465 |
| | 43 |
|
Below investment grade | | 911 |
| | 908 |
| | 4 |
| | 1,176 |
| | 1,200 |
| | 5 |
|
Total fixed maturities | | $ | 20,928 |
| | $ | 21,472 |
| | 100 | % | | $ | 20,764 |
| | $ | 22,155 |
| | 100 | % |
As of September 30, 2018 and December 31, 2017, approximately 34% and 35%, respectively, of the securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities. The Company had holdings of $456 million in AT&T, Inc., which were greater than 10% of total equity as of September 30, 2018. There were no other holdings of any other issuer greater than 10% of total equity as of both September 30, 2018 and December 31, 2017.
The following tables provide information about Available-for-Sale securities with gross unrealized losses and the length of time that individual securities have been in a continuous unrealized loss position:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Description of Securities | September 30, 2018 |
Less than 12 months | | 12 months or more | | Total |
Number of Securities | | Fair Value | | Unrealized Losses | Number of Securities | | Fair Value | | Unrealized Losses | Number of Securities | | Fair Value | | Unrealized Losses |
| (in millions, except number of securities) |
Corporate debt securities | 271 |
| | $ | 4,580 |
| | $ | (91 | ) | | 48 |
| | $ | 455 |
| | $ | (35 | ) | | 319 |
| | $ | 5,035 |
| | $ | (126 | ) |
Residential mortgage backed securities | 85 |
| | 1,522 |
| | (28 | ) | | 44 |
| | 733 |
| | (43 | ) | | 129 |
| | 2,255 |
| | (71 | ) |
Commercial mortgage backed securities | 100 |
| | 1,722 |
| | (57 | ) | | 65 |
| | 1,093 |
| | (68 | ) | | 165 |
| | 2,815 |
| | (125 | ) |
State and municipal obligations | 27 |
| | 117 |
| | (2 | ) | | 16 |
| | 112 |
| | (3 | ) | | 43 |
| | 229 |
| | (5 | ) |
Asset backed securities | 24 |
| | 295 |
| | (3 | ) | | 12 |
| | 58 |
| | (2 | ) | | 36 |
| | 353 |
| | (5 | ) |
Foreign government bonds and obligations | 15 |
| | 53 |
| | (3 | ) | | 14 |
| | 17 |
| | (5 | ) | | 29 |
| | 70 |
| | (8 | ) |
Total | 522 |
| | $ | 8,289 |
| | $ | (184 | ) | | 199 |
| | $ | 2,468 |
| | $ | (156 | ) | | 721 |
| | $ | 10,757 |
| | $ | (340 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Description of Securities | December 31, 2017 |
Less than 12 months | | 12 months or more | | Total |
Number of Securities | | Fair Value | | Unrealized Losses | Number of Securities | | Fair Value | | Unrealized Losses | Number of Securities | | Fair Value | | Unrealized Losses |
| (in millions, except number of securities) |
Corporate debt securities | 82 |
| | $ | 834 |
| | $ | (5 | ) | | 39 |
| | $ | 360 |
| | $ | (20 | ) | | 121 |
| | $ | 1,194 |
| | $ | (25 | ) |
Residential mortgage backed securities | 36 |
| | 546 |
| | (4 | ) | | 41 |
| | 657 |
| | (18 | ) | | 77 |
| | 1,203 |
| | (22 | ) |
Commercial mortgage backed securities | 56 |
| | 994 |
| | (10 | ) | | 42 |
| | 663 |
| | (22 | ) | | 98 |
| | 1,657 |
| | (32 | ) |
State and municipal obligations | 19 |
| | 35 |
| | — |
| | 8 |
| | 138 |
| | (9 | ) | | 27 |
| | 173 |
| | (9 | ) |
Asset backed securities | 15 |
| | 116 |
| | — |
| | 12 |
| | 76 |
| | (2 | ) | | 27 |
| | 192 |
| | (2 | ) |
Foreign government bonds and obligations | 3 |
| | 6 |
| | — |
| | 15 |
| | 23 |
| | (4 | ) | | 18 |
| | 29 |
| | (4 | ) |
Common stocks | — |
| | — |
| | — |
| | 3 |
| | 1 |
| | (1 | ) | | 3 |
| | 1 |
| | (1 | ) |
Total | 211 |
| | $ | 2,531 |
| | $ | (19 | ) | | 160 |
| | $ | 1,918 |
| | $ | (76 | ) | | 371 |
| | $ | 4,449 |
| | $ | (95 | ) |
As part of the Company’s ongoing monitoring process, management determined that the change in gross unrealized losses on its Available-for-Sale securities is primarily attributable to an increase in interest rates as well as slightly wider credit spreads.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
The following table presents a rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on Available-for-Sale securities for which a portion of the securities’ total other-than-temporary impairments was recognized in OCI:
|
| | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
2018 | | 2017 | | 2018 | | 2017 |
(in millions) |
Beginning balance | $ | — |
| | $ | — |
| | $ | — |
| | $ | 21 |
|
Reductions for securities sold during the period (realized) | — |
| | — |
| | — |
| | (21 | ) |
Ending balance | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
|
Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains (losses) were as follows:
|
| | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
2018 | | 2017 | | 2018 | | 2017 |
(in millions) |
Gross realized investment gains | $ | 4 |
| | $ | 5 |
| | $ | 14 |
| | $ | 38 |
|
Gross realized investment losses | — |
| | (2 | ) | | — |
| | (4 | ) |
Total | $ | 4 |
| | $ | 3 |
| | $ | 14 |
| | $ | 34 |
|
See Note 15 for a rollforward of net unrealized investment gains (losses) included in AOCI.
Available-for-Sale securities by contractual maturity as of September 30, 2018 were as follows:
|
| | | | | | | |
| Amortized Cost | | Fair Value |
(in millions) |
Due within one year | $ | 1,320 |
| | $ | 1,337 |
|
Due after one year through five years | 4,853 |
| | 4,876 |
|
Due after five years through 10 years | 3,383 |
| | 3,358 |
|
Due after 10 years | 4,014 |
| | 4,685 |
|
| 13,570 |
| | 14,256 |
|
Residential mortgage backed securities | 2,959 |
| | 2,907 |
|
Commercial mortgage backed securities | 3,748 |
| | 3,638 |
|
Asset backed securities | 651 |
| | 671 |
|
Total | $ | 20,928 |
| | $ | 21,472 |
|
Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities were not included in the maturities distribution.
The following is a summary of net investment income:
|
| | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
2018 | | 2017 | | 2018 | | 2017 |
(in millions) |
Fixed maturities | $ | 227 |
| | $ | 237 |
| | $ | 686 |
| | $ | 717 |
|
Mortgage loans | 29 |
| | 34 |
| | 88 |
| | 103 |
|
Other investments | (7 | ) | | (4 | ) | | 1 |
| | (4 | ) |
| 249 |
| | 267 |
| | 775 |
| | 816 |
|
Less: investment expenses | 6 |
| | 6 |
| | 18 |
| | 19 |
|
Total | $ | 243 |
| | $ | 261 |
| | $ | 757 |
| | $ | 797 |
|
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
6. Financing Receivables
The Company’s financing receivables include commercial mortgage loans, syndicated loans and policy loans. Syndicated loans are reflected in other investments.
Allowance for Loan Losses
Policy loans do not exceed the cash surrender value of the policy at origination. As there is minimal risk of loss related to policy loans, the Company does not record an allowance for loan losses for policy loans.
The following table presents a rollforward of the allowance for loan losses for the nine months ended and the ending balance of the allowance for loan losses by impairment method:
|
| | | | | | | |
| September 30, |
2018 | | 2017 |
(in millions) |
Beginning balance | $ | 22 |
| | $ | 25 |
|
Charge-offs | (2 | ) | | — |
|
Ending balance | $ | 20 |
|
| $ | 25 |
|
| | | |
Individually evaluated for impairment | $ | — |
| | $ | 3 |
|
Collectively evaluated for impairment | 20 |
| | 22 |
|
The recorded investment in financing receivables by impairment method was as follows:
|
| | | | | | | |
| September 30, 2018 | | December 31, 2017 |
(in millions) |
Individually evaluated for impairment | $ | 14 |
| | $ | 17 |
|
Collectively evaluated for impairment | 2,937 |
| | 3,015 |
|
Total | $ | 2,951 |
| | $ | 3,032 |
|
As of September 30, 2018 and December 31, 2017, the Company’s recorded investment in financing receivables individually evaluated for impairment for which there was no related allowance for loan losses was $8 million and $17 million, respectively.
During the three months ended September 30, 2018 and 2017, the Company purchased $21 million and $14 million, respectively, of syndicated loans and sold $13 million and $9 million, respectively, of syndicated loans. During the nine months ended September 30, 2018 and 2017, the Company purchased $109 million and $121 million, respectively, of syndicated loans and sold $43 million and $12 million, respectively, of syndicated loans.
Credit Quality Information
Nonperforming loans, which are generally loans 90 days or more past due, were nil and $5 million as of September 30, 2018 and December 31, 2017, respectively. All other loans were considered to be performing.
Commercial Mortgage Loans
The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on commercial mortgage loans. Based on this review, the commercial mortgage loans are assigned an internal risk rating, which management updates as necessary. Commercial mortgage loans which management has assigned its highest risk rating were nil of total commercial mortgage loans as of both September 30, 2018 and December 31, 2017. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. In addition, the Company reviews the concentrations of credit risk by region and property type.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows:
|
| | | | | | | | | | | | | |
| Loans | | Percentage |
September 30, 2018 | | December 31, 2017 | | September 30, 2018 | | December 31, 2017 |
(in millions) | | | | |
South Atlantic | $ | 703 |
| | $ | 735 |
| | 27 | % | | 28 | % |
Pacific | 761 |
| | 771 |
| | 30 |
| | 29 |
|
Mountain | 228 |
| | 242 |
| | 9 |
| | 9 |
|
West North Central | 211 |
| | 223 |
| | 8 |
| | 8 |
|
East North Central | 204 |
| | 209 |
| | 8 |
| | 8 |
|
Middle Atlantic | 172 |
| | 179 |
| | 7 |
| | 7 |
|
West South Central | 132 |
| | 125 |
| | 5 |
| | 5 |
|
New England | 55 |
| | 67 |
| | 2 |
| | 3 |
|
East South Central | 90 |
| | 84 |
| | 4 |
| | 3 |
|
| 2,556 |
| | 2,635 |
| | 100 | % | | 100 | % |
Less: allowance for loan losses | 16 |
| | 16 |
| | |
| | |
|
Total | $ | 2,540 |
| | $ | 2,619 |
| | |
| | |
|
Concentrations of credit risk of commercial mortgage loans by property type were as follows:
|
| | | | | | | | | | | | | |
| Loans | | Percentage |
September 30, 2018 | | December 31, 2017 | | September 30, 2018 | | December 31, 2017 |
(in millions) | | | | |
Retail | $ | 856 |
| | $ | 893 |
| | 33 | % |
| 34 | % |
Office | 419 |
| | 470 |
| | 16 |
| | 18 |
|
Apartments | 565 |
| | 536 |
| | 22 |
| | 20 |
|
Industrial | 424 |
| | 451 |
| | 17 |
| | 17 |
|
Mixed use | 38 |
| | 38 |
| | 2 |
| | 1 |
|
Hotel | 43 |
| | 39 |
| | 2 |
| | 2 |
|
Other | 211 |
| | 208 |
| | 8 |
| | 8 |
|
| 2,556 |
| | 2,635 |
| | 100 | % | | 100 | % |
Less: allowance for loan losses | 16 |
| | 16 |
| | |
| | |
|
Total | $ | 2,540 |
| | $ | 2,619 |
| | |
| | |
|
Syndicated Loans
The recorded investment in syndicated loans as of September 30, 2018 and December 31, 2017 was $394 million and $397 million, respectively. The Company’s syndicated loan portfolio is diversified across industries and issuers. The primary credit indicator for syndicated loans is whether the loans are performing in accordance with the contractual terms of the syndication. Total nonperforming syndicated loans as of September 30, 2018 and December 31, 2017 were nil and $5 million, respectively.
Troubled Debt Restructurings
The recorded investment in restructured loans was not material as of both September 30, 2018 and December 31, 2017. The troubled debt restructurings did not have a material impact to the Company’s allowance for loan losses or income recognized for the three months and nine months ended September 30, 2018 and 2017. There are no commitments to lend additional funds to borrowers whose loans have been restructured.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
7. Deferred Acquisition Costs and Deferred Sales Inducement Costs
In the third quarter of the year, management updated market-related inputs and implemented model changes related to the living benefit valuation. In addition, management conducted its annual review of life insurance and annuity valuation assumptions relative to current experience and management expectations including modeling changes. These aforementioned changes are collectively referred to as unlocking. The impact of unlocking to DAC in the third quarter of 2018 primarily reflected updated mortality assumptions on universal life (“UL”) and variable universal life (“VUL”) insurance products and lower surrender rate assumptions on variable annuities, partially offset by an unfavorable impact from updates to assumptions on utilization of guaranteed withdrawal benefits. The impact of unlocking to DAC in the third quarter of 2017 primarily reflected improved persistency and mortality on UL and VUL insurance products and a correction related to a variable annuity model assumption partially offset by updates to market-related inputs to the living benefit valuation.
The balances of and changes in DAC were as follows:
|
| | | | | | | |
| 2018 | | 2017 |
(in millions) |
Balance at January 1 | $ | 2,639 |
| | $ | 2,611 |
|
Capitalization of acquisition costs | 192 |
| | 173 |
|
Amortization, excluding the impact of valuation assumptions review | (166 | ) | | (154 | ) |
Amortization, impact of valuation assumptions review | 33 |
| | 12 |
|
Impact of change in net unrealized (gains) losses on securities | 95 |
| | (18 | ) |
Balance at September 30 | $ | 2,793 |
| | $ | 2,624 |
|
The balances of and changes in DSIC, which is included in other assets, were as follows:
|
| | | | | | | |
| 2018 | | 2017 |
(in millions) |
Balance at January 1 | $ | 273 |
| | $ | 301 |
|
Capitalization of sales inducement costs | 2 |
| | 3 |
|
Amortization, excluding the impact of valuation assumptions review | (26 | ) | | (27 | ) |
Amortization, impact of valuation assumptions review | — |
| | (1 | ) |
Impact of change in net unrealized (gains) losses on securities | 16 |
| | 1 |
|
Balance at September 30 | $ | 265 |
| | $ | 277 |
|
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
8. Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities
Policyholder account balances, future policy benefits and claims consisted of the following:
|
| | | | | | | | |
| September 30, 2018 | | December 31, 2017 | |
(in millions) | |
Policyholder account balances | | | | |
Fixed annuities (1) | $ | 9,499 |
| | $ | 9,934 |
| |
Variable annuity fixed sub-accounts | 5,127 |
| | 5,166 |
| |
VUL/UL insurance | 3,057 |
| | 3,047 |
| |
Indexed universal life (“IUL”) insurance | 1,649 |
| | 1,384 |
| |
Other life insurance | 689 |
| | 720 |
| |
Total policyholder account balances | 20,021 |
| | 20,251 |
| |
| | | | |
Future policy benefits | | | | |
Variable annuity guaranteed minimum withdrawal benefits (“GMWB”) | (125 | ) | (2) | 463 |
| |
Variable annuity guaranteed minimum accumulation benefits (“GMAB”) | (83 | ) | (3) | (80 | ) | (3) |
Other annuity liabilities | 26 |
| | 78 |
| |
Fixed annuity life contingent liabilities | 1,464 |
| | 1,484 |
| |
Life and disability income insurance | 1,219 |
| | 1,221 |
| |
Long term care insurance | 4,997 |
| | 4,896 |
| |
VUL/UL and other life insurance additional liabilities | 807 |
| | 688 |
| |
Total future policy benefits | 8,305 |
| | 8,750 |
| |
Policy claims and other policyholders’ funds | 150 |
| | 177 |
| |
Total policyholder account balances, future policy benefits and claims | $ | 28,476 |
| | $ | 29,178 |
| |
| |
(2) | September 30, 2018 reported as a contra liability. |
| |
(3) | September 30, 2018 and December 31, 2017 reported as a contra liability. |
Separate account liabilities consisted of the following:
|
| | | | | | | |
| September 30, 2018 | | December 31, 2017 |
(in millions) |
Variable annuity | $ | 74,317 |
| | $ | 75,174 |
|
VUL insurance | 7,338 |
| | 7,352 |
|
Other insurance | 33 |
| | 34 |
|
Total | $ | 81,688 |
| | $ | 82,560 |
|
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
9. Variable Annuity and Insurance Guarantees
The majority of the variable annuity contracts offered by the Company contain guaranteed minimum death benefit (“GMDB”) provisions. The Company also offers variable annuities with death benefit provisions that gross up the amount payable by a certain percentage of contract earnings, which are referred to as gain gross-up (“GGU”) benefits. In addition, the Company offers contracts with GMWB and GMAB provisions. The Company previously offered contracts containing guaranteed minimum income benefit (“GMIB”) provisions.
Certain UL policies offered by the Company provide secondary guarantee benefits. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges.
The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Variable Annuity Guarantees by Benefit Type (1) | September 30, 2018 | | December 31, 2017 |
Total Contract Value | | Contract Value in Separate Accounts | | Net Amount at Risk | | Weighted Average Attained Age | Total Contract Value | | Contract Value in Separate Accounts | | Net Amount at Risk | | Weighted Average Attained Age |
| (in millions, except age) |
GMDB: | | | | | | | | | | | | | | | |
Return of premium | $ | 61,379 |
| | $ | 59,441 |
| | $ | 12 |
| | 67 | | $ | 61,418 |
| | $ | 59,461 |
| | $ | 9 |
| | 66 |
Five/six-year reset | 8,504 |
| | 5,781 |
| | 11 |
| | 66 | | 8,870 |
| | 6,149 |
| | 12 |
| | 66 |
One-year ratchet | 6,215 |
| | 5,864 |
| | 19 |
| | 69 | | 6,548 |
| | 6,187 |
| | 11 |
| | 69 |
Five-year ratchet | 1,471 |
| | 1,416 |
| | 1 |
| | 65 | | 1,563 |
| | 1,506 |
| | 1 |
| | 65 |
Other | 1,126 |
| | 1,107 |
| | 63 |
| | 72 | | 1,099 |
| | 1,075 |
| | 50 |
| | 72 |
Total — GMDB | $ | 78,695 |
| | $ | 73,609 |
| | $ | 106 |
| | 67 | | $ | 79,498 |
| | $ | 74,378 |
| | $ | 83 |
| | 66 |
| | | | | | | | | | | | | | | |
GGU death benefit | $ | 1,105 |
| | $ | 1,055 |
| | $ | 129 |
| | 70 | | $ | 1,118 |
| | $ | 1,067 |
| | $ | 133 |
| | 70 |
| | | | | | | | | | | | | | | |
GMIB | $ | 208 |
| | $ | 192 |
| | $ | 7 |
| | 69 | | $ | 233 |
| | $ | 216 |
| | $ | 7 |
| | 69 |
| | | | | | | | | | | | | | | |
GMWB: | | | | | | | | | | | | | | | |
GMWB | $ | 2,252 |
| | $ | 2,245 |
| | $ | 1 |
| | 72 | | $ | 2,508 |
| | $ | 2,500 |
| | $ | 1 |
| | 71 |
GMWB for life | 44,871 |
| | 44,776 |
| | 217 |
| | 68 | | 44,375 |
| | 44,259 |
| | 129 |
| | 67 |
Total — GMWB | $ | 47,123 |
| | $ | 47,021 |
| | $ | 218 |
| | 68 | | $ | 46,883 |
| | $ | 46,759 |
| | $ | 130 |
| | 67 |
| | | | | | | | | | | | | | | |
GMAB | $ | 2,762 |
| | $ | 2,758 |
| | $ | — |
| | 59 | | $ | 3,086 |
| | $ | 3,083 |
| | $ | — |
| | 59 |
The net amount at risk for GMDB, GGU and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero.
The following table provides information related to insurance guarantees for which the Company has established additional liabilities:
|
| | | | | | | | | | | |
| September 30, 2018 | | December 31, 2017 |
Net Amount at Risk | | Weighted Average Attained Age | Net Amount at Risk | | Weighted Average Attained Age |
(in millions, except age) |
UL secondary guarantees | $ | 6,499 |
| | 66 | | $ | 6,460 |
| | 65 |
The net amount at risk for UL secondary guarantees is defined as the current guaranteed death benefit amount in excess of the current policyholder account balance.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows:
|
| | | | | | | | | | | | | | | | | | | |
| GMDB & GGU | | GMIB | | GMWB (1) | | GMAB (1) | | UL |
(in millions) |
Balance at January 1, 2017 | $ | 16 |
| | $ | 8 |
| | $ | 1,017 |
| | $ | (24 | ) | | $ | 434 |
|
Incurred claims | 3 |
| | — |
| | (478 | ) | | (49 | ) | | 59 |
|
Paid claims | (3 | ) | | (1 | ) | | — |
| | — |
| | (22 | ) |
Balance at September 30, 2017 | $ | 16 |
| | $ | 7 |
| | $ | 539 |
| | $ | (73 | ) | | $ | 471 |
|
| | | | | | | | | |
Balance at January 1, 2018 | $ | 17 |
| | $ | 6 |
| | $ | 463 |
| | $ | (80 | ) | | $ | 489 |
|
Incurred claims | 5 |
| | — |
| | (588 | ) | | (3 | ) | | 171 |
|
Paid claims | (4 | ) | | — |
| | — |
| | — |
| | (19 | ) |
Balance at September 30, 2018 | $ | 18 |
| | $ | 6 |
| | $ | (125 | ) | | $ | (83 | ) | | $ | 641 |
|
The liabilities for guaranteed benefits are supported by general account assets.
The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits:
|
| | | | | | | |
| September 30, 2018 | | December 31, 2017 |
(in millions) |
Mutual funds: | |
| | |
|
Equity | $ | 44,968 |
| | $ | 46,038 |
|
Bond | 22,846 |
| | 23,529 |
|
Other | 6,059 |
| | 5,109 |
|
Total mutual funds | $ | 73,873 |
| | $ | 74,676 |
|
10. Short-term Borrowings
The Company enters into repurchase agreements in exchange for cash which it accounts for as secured borrowings and has pledged Available-for-Sale securities to collateralize its obligations under the repurchase agreements. As of September 30, 2018 and December 31, 2017, the Company has pledged $53 million and $43 million, respectively, of agency residential mortgage backed securities and nil and $8 million, respectively, of commercial mortgage backed securities. The amount of the Company’s liability including accrued interest as of both September 30, 2018 and December 31, 2017 was $50 million. The remaining maturity of outstanding repurchase agreements was less than three months as of September 30, 2018 and less than one month as of December 31, 2017. The weighted average annualized interest rate on repurchase agreements held as of September 30, 2018 and December 31, 2017 was 2.3% and 1.4%, respectively.
RiverSource Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Des Moines which provides access to collateralized borrowings. The Company has pledged Available-for-Sale securities consisting of commercial mortgage backed securities to collateralize its obligation under these borrowings. The fair value of the securities pledged is recorded in investments and was $788 million and $750 million as of September 30, 2018 and December 31, 2017, respectively. The amount of the Company’s liability including accrued interest as of September 30, 2018 and December 31, 2017 was $151 million and $150 million, respectively. The remaining maturity of outstanding FHLB advances was less than three months as of September 30, 2018 and less than four months as of December 31, 2017. The weighted average annualized interest rate on outstanding borrowings as of September 30, 2018 and December 31, 2017 was 2.3% and 1.5%, respectively.
11. Fair Values of Assets and Liabilities
GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Valuation Hierarchy
The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
| |
Level 1 | Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. |
| |
Level 2 | Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. |
| |
Level 3 | Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. |
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis:
|
| | | | | | | | | | | | | | | | |
| September 30, 2018 | |
Level 1 | | Level 2 | | Level 3 | | Total |
(in millions) |
Assets | |
| | |
| | |
| | |
| |
Available-for-Sale securities: Fixed maturities: | |
| | |
| | |
| | |
| |
Corporate debt securities | $ | — |
| | $ | 11,729 |
| | $ | 950 |
| | $ | 12,679 |
| |
Residential mortgage backed securities | — |
| | 2,842 |
| | 65 |
| | 2,907 |
| |
Commercial mortgage backed securities | — |
| | 3,638 |
| | — |
| | 3,638 |
| |
State and municipal obligations | — |
| | 1,278 |
| | — |
| | 1,278 |
| |
Asset backed securities | — |
| | 671 |
| | — |
| | 671 |
| |
Foreign government bonds and obligations | — |
| | 298 |
| | — |
| | 298 |
| |
U.S. government and agency obligations | 1 |
| | — |
| | — |
| | 1 |
| |
Total Available-for-Sale securities: Fixed maturities | 1 |
| | 20,456 |
| | 1,015 |
| | 21,472 |
| |
Equity securities | 1 |
| | — |
| | — |
| | 1 |
| |
Cash equivalents | — |
| | 635 |
| | — |
| | 635 |
| |
Other assets: | | | | | | | |
| |
Interest rate derivative contracts | — |
| | 609 |
| | — |
| | 609 |
| |
Equity derivative contracts | 87 |
| | 2,544 |
| | — |
| | 2,631 |
| |
Foreign exchange derivative contracts | — |
| | 43 |
| | — |
| | 43 |
| |
Credit derivative contracts | — |
| | 7 |
| | — |
| | 7 |
| |
Total other assets | 87 |
|
| 3,203 |
| | — |
| | 3,290 |
| |
Separate account assets at net asset value (“NAV”) | | | | | | | 81,688 |
| (1) |
Total assets at fair value | $ | 89 |
| | $ | 24,294 |
| | $ | 1,015 |
| | $ | 107,086 |
| |
|
| | | | | | | | | | | | | | | | |
Liabilities | |
| | |
| | |
| | |
| |
Policyholder account balances, future policy benefits and claims: | |
| | |
| | |
| | |
| |
Indexed annuity embedded derivatives | $ | — |
| | $ | 4 |
| | $ | 11 |
| | $ | 15 |
| |
IUL embedded derivatives | — |
| | — |
| | 684 |
| | 684 |
| |
GMWB and GMAB embedded derivatives | — |
| | — |
| | (686 | ) | | (686 | ) | (2) |
Total policyholder account balances, future policy benefits and claims | — |
| | 4 |
| | 9 |
| | 13 |
| (3) |
Other liabilities: | |
| | |
| | |
| | |
| |
Interest rate derivative contracts | 1 |
| | 601 |
| | — |
| | 602 |
| |
Equity derivative contracts | 13 |
| | 3,005 |
| | — |
| | 3,018 |
| |
Foreign exchange derivative contracts | — |
| | 27 |
| | — |
| | 27 |
| |
Total other liabilities | 14 |
| | 3,633 |
| | — |
| | 3,647 |
| |
Total liabilities at fair value | $ | 14 |
| | $ | 3,637 |
| | $ | 9 |
| | $ | 3,660 |
| |
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
|
| | | | | | | | | | | | | | | | |
| December 31, 2017 | |
Level 1 | | Level 2 | | Level 3 | | Total |
(in millions) |
Assets | |
| | |
| | |
| | |
| |
Available-for-Sale securities: Fixed maturities: | |
| | |
| | |
| | |
| |
Corporate debt securities | $ | — |
| | $ | 12,161 |
| | $ | 1,072 |
| | $ | 13,233 |
| |
Residential mortgage backed securities | — |
| | 2,924 |
| | 87 |
| | 3,011 |
| |
Commercial mortgage backed securities | — |
| | 3,569 |
| | — |
| | 3,569 |
| |
State and municipal obligations | — |
| | 1,314 |
| | — |
| | 1,314 |
| |
Asset backed securities | — |
| | 728 |
| | — |
| | 728 |
| |
Foreign government bonds and obligations | — |
| | 299 |
| | — |
| | 299 |
| |
U.S. government and agency obligations | 1 |
| | — |
| | — |
| | 1 |
| |
Total Available-for-Sale securities: Fixed maturities | 1 |
| | 20,995 |
| | 1,159 |
| | 22,155 |
| |
Cash equivalents | — |
| | 1,030 |
| | — |
| | 1,030 |
| |
Other assets: | |
| | |
| | |
| | |
| |
Interest rate derivative contracts | — |
| | 1,081 |
| | — |
| | 1,081 |
| |
Equity derivative contracts | 62 |
| | 2,305 |
| | — |
| | 2,367 |
| |
Foreign exchange derivative contracts | 1 |
| | 34 |
| | — |
| | 35 |
| |
Total other assets | 63 |
| | 3,420 |
| | — |
| | 3,483 |
| |
Separate account assets at NAV | | | | | | | 82,560 |
| (1) |
Total assets at fair value | $ | 64 |
| | $ | 25,445 |
| | $ | 1,159 |
| | $ | 109,228 |
| |
|
| | | | | | | | | | | | | | | | |
Liabilities | |
| | |
| | |
| | |
| |
Policyholder account balances, future policy benefits and claims: | |
| | |
| | |
| | |
| |
Indexed annuity embedded derivatives | $ | — |
| | $ | 5 |
| | $ | — |
| | $ | 5 |
| |
IUL embedded derivatives | — |
| | — |
| | 601 |
| | 601 |
| |
GMWB and GMAB embedded derivatives | — |
| | — |
| | (49 | ) | | (49 | ) | (4) |
Total policyholder account balances, future policy benefits and claims | — |
| | 5 |
| | 552 |
| | 557 |
| (5) |
Other liabilities: | |
| | |
| | |
| | |
| |
Interest rate derivative contracts | 1 |
| | 414 |
| | — |
| | 415 |
| |
Equity derivative contracts | 5 |
| | 2,666 |
| | — |
| | 2,671 |
| |
Foreign exchange derivative contracts | — |
| | 23 |
| | — |
| | 23 |
| |
Credit derivative contracts | — |
| | 2 |
| | — |
| | 2 |
| |
Total other liabilities | 6 |
| | 3,105 |
| | — |
| | 3,111 |
| |
Total liabilities at fair value | $ | 6 |
| | $ | 3,110 |
| | $ | 552 |
| | $ | 3,668 |
| |
| |
(2) | $178 million of individual contracts in a liability position and $864 million of individual contracts in an asset position as of September 30, 2018. |
| |
(3) | $(370) million cumulative increase (decrease) to the embedded derivatives as of September 30, 2018. |
| |
(4) | $443 million of individual contracts in a liability position and $492 million of individual contracts in an asset position as of December 31, 2017. |
| |
(5) | $(399) million cumulative increase (decrease) to the embedded derivatives as of December 31, 2017. |
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| Available-for-Sale Securities: Fixed Maturities | | Other Derivative Contracts | |
Corporate Debt Securities | | Residential Mortgage Backed Securities | | Commercial Mortgage Backed Securities | | Asset Backed Securities | | Total |
(in millions) | | | |
Balance, July 1, 2018 | $ | 998 |
| | $ | 69 |
| | $ | 12 |
| | $ | 10 |
| | $ | 1,089 |
| | $ | 2 |
| |
Total gains (losses) included in: | | | | | | | | | | | | |
Net income | — |
| | — |
| | — |
| | — |
| | — |
| | (2 | ) | (1) |
Other comprehensive income | (2 | ) | | — |
| | — |
| | — |
| | (2 | ) | | — |
| |
Settlements | (46 | ) | | (1 | ) | | — |
| | — |
| | (47 | ) | | — |
| |
Transfers out Level 3 | — |
| | (3 | ) | | (12 | ) | | (10 | ) | | (25 | ) | | — |
| |
Balance, September 30, 2018 | $ | 950 |
| | $ | 65 |
| | $ | — |
| | $ | — |
| | $ | 1,015 |
| | $ | — |
| |
| | | | | | | | | | | | |
Changes in unrealized gains (losses) relating to assets held at September 30, 2018 | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | (2 | ) | (1) |
|
| | | | | | | | | | | | | | | |
| Policyholder Account Balances, Future Policy Benefits and Claims |
Indexed Annuity Embedded Derivatives | | IUL Embedded Derivatives | | GMWB and GMAB Embedded Derivatives | | Total |
(in millions) |
Balance, July 1, 2018 | $ | 8 |
| | $ | 620 |
| | $ | (425 | ) | | $ | 203 |
|
Total (gains) losses included in: | | | |
| | |
| | |
Net income | — |
| | 55 |
| (2) | (344 | ) | (1) | (289 | ) |
Issues | 3 |
| | 24 |
| | 90 |
| | 117 |
|
Settlements | — |
| | (15 | ) | | (7 | ) | | (22 | ) |
Balance, September 30, 2018 | $ | 11 |
| | $ | 684 |
| | $ | (686 | ) | | $ | 9 |
|
| | | | | | | |
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2018 | $ | — |
| | $ | 55 |
| (2) | $ | (347 | ) | (1) | $ | (292 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Available-for-Sale Securities: Fixed Maturities | | Common Stocks |
Corporate Debt Securities | | Residential Mortgage Backed Securities | | Commercial Mortgage Backed Securities | | Asset Backed Securities | | Total |
(in millions) | | |
Balance, July 1, 2017 | $ | 1,190 |
| | $ | 89 |
| | $ | — |
| | $ | 11 |
| | $ | 1,290 |
| | $ | — |
|
Total gains (losses) included in: | | | | | | | | | | | |
Net income | 1 |
| | — |
| | — |
| | — |
| | 1 |
| (3) | — |
|
Other comprehensive income | (1 | ) | | 1 |
| | — |
| | — |
| | — |
| | — |
|
Purchases | 38 |
| | — |
| | 35 |
| | — |
| | 73 |
| | — |
|
Settlements | (82 | ) | | (1 | ) | | — |
| | — |
| | (83 | ) | | — |
|
Transfers into Level 3 | — |
| | — |
| | — |
| | — |
| | — |
| | 1 |
|
Transfers out of Level 3 | — |
| | — |
| | — |
| | (11 | ) | | (11 | ) | | — |
|
Balance, September 30, 2017 | $ | 1,146 |
| | $ | 89 |
| | $ | 35 |
| | $ | — |
| | $ | 1,270 |
| | $ | 1 |
|
| | | | | | | | | | | |
Changes in unrealized gains (losses) relating to assets held at September 30, 2017 | $ | 1 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
| (3) | $ | — |
|
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
|
| | | | | | | | | | | |
| Policyholder Account Balances, Future Policy Benefits and Claims |
IUL Embedded Derivatives | | GMWB and GMAB Embedded Derivatives | | Total |
(in millions) |
Balance, July 1, 2017 | $ | 527 |
| | $ | 272 |
| | $ | 799 |
|
Total (gains) losses included in: | |
| | |
| | |
Net income | 35 |
| (2) | (309 | ) | (1) | (274 | ) |
Issues | 26 |
| | 84 |
| | 110 |
|
Settlements | (11 | ) | | (2 | ) | | (13 | ) |
Balance, September 30, 2017 | $ | 577 |
| | $ | 45 |
| | $ | 622 |
|
| | | | | |
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2017 | $ | 35 |
| (2) | $ | (307 | ) | (1) | $ | (272 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| Available-for-Sale Securities: Fixed Maturities | | Other Derivative Contracts | |
Corporate Debt Securities | | Residential Mortgage Backed Securities | | Commercial Mortgage Backed Securities | | Asset Backed Securities | | Total |
(in millions) | | | |
Balance, January 1, 2018 | $ | 1,072 |
| | $ | 87 |
| | $ | — |
| | $ | — |
| | $ | 1,159 |
| | $ | — |
| |
Total gains (losses) included in: | | | | | | | | | | | | |
Net income | (1 | ) | | — |
| | — |
| | — |
| | (1 | ) | (3) | (3 | ) | (1) |
Other comprehensive income | (28 | ) | | 1 |
| | — |
| | — |
| | (27 | ) | | — |
| |
Purchases | 15 |
| | — |
| | 12 |
| | 10 |
| | 37 |
| | 3 |
| |
Settlements | (108 | ) | | (5 | ) | | — |
| | — |
| | (113 | ) | | — |
| |
Transfers out of Level 3 | — |
| | (18 | ) | | (12 | ) | | (10 | ) | | (40 | ) | | — |
| |
Balance, September 30, 2018 | $ | 950 |
| | $ | 65 |
| | $ | — |
| | $ | — |
| | $ | 1,015 |
| | $ | — |
| |
| | | | | | | | | | | | |
Changes in unrealized gains (losses) relating to assets held at September 30, 2018 | $ | (1 | ) | | $ | — |
| | $ | — |
| | $ | — |
| | $ | (1 | ) | (3) | $ | (3 | ) | (1) |
|
| | | | | | | | | | | | | | | |
| Policyholder Account Balances, Future Policy Benefits and Claims |
Indexed Annuity Embedded Derivatives | | IUL Embedded Derivatives | | GMWB and GMAB Embedded Derivatives | | Total |
(in millions) |
Balance, January 1, 2018 | $ | — |
| | $ | 601 |
| | $ | (49 | ) | | $ | 552 |
|
Total (gains) losses included in: | | | |
| | |
| | |
Net income | — |
| | 56 |
| (2) | (875 | ) | (1) | (819 | ) |
Issues | 11 |
| | 65 |
| | 257 |
| | 333 |
|
Settlements | — |
| | (38 | ) | | (19 | ) | | (57 | ) |
Balance, September 30, 2018 | $ | 11 |
| | $ | 684 |
| | $ | (686 | ) | | $ | 9 |
|
| | | | | | | |
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2018 | $ | — |
| | $ | 56 |
| (2) | $ | (868 | ) | (1) | $ | (812 | ) |
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Available-for-Sale Securities: Fixed Maturities | | Common Stocks |
Corporate Debt Securities | | Residential Mortgage Backed Securities | | Commercial Mortgage Backed Securities | | Asset Backed Securities | | Total |
(in millions) | | |
Balance, January 1, 2017 | $ | 1,157 |
| | $ | 115 |
| | $ | — |
| | $ | 13 |
| | $ | 1,285 |
| | $ | — |
|
Total gains (losses) included in: | | | | | | | | | | | |
Net income | 1 |
| | — |
| | — |
| | — |
| | 1 |
| (3) | — |
|
Other comprehensive income | 1 |
| | 1 |
| | — |
| | — |
| | 2 |
| | — |
|
Purchases | 96 |
| | 67 |
| | 35 |
| | 49 |
| | 247 |
| | — |
|
Settlements | (109 | ) | | (5 | ) | | — |
| | (13 | ) | | (127 | ) | | — |
|
Transfers into Level 3 | — |
| | — |
| | — |
| | 11 |
| | 11 |
| | 5 |
|
Transfers out of Level 3 | — |
| | (89 | ) | | — |
| | (60 | ) | | (149 | ) | | (4 | ) |
Balance, September 30, 2017 | $ | 1,146 |
| | $ | 89 |
| | $ | 35 |
| | $ | — |
| | $ | 1,270 |
| | $ | 1 |
|
| | | | | | | | | | | |
Changes in unrealized gains (losses) relating to assets held at September 30, 2017 | $ | 1 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
| (3) | $ | — |
|
|
| | | | | | | | | | | |
| Policyholder Account Balances, Future Policy Benefits and Claims |
IUL Embedded Derivatives | | GMWB and GMAB Embedded Derivatives | | Total |
(in millions) |
Balance, January 1, 2017 | $ | 464 |
| | $ | 614 |
| | $ | 1,078 |
|
Total (gains) losses included in: | |
| | |
| | |
Net income | 75 |
| (2) | (798 | ) | (1) | (723 | ) |
Issues | 70 |
| | 238 |
| | 308 |
|
Settlements | (32 | ) | | (9 | ) | | (41 | ) |
Balance, September 30, 2017 | $ | 577 |
| | $ | 45 |
| | $ | 622 |
|
| | | | | |
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2017 | $ | 75 |
| (2) | $ | (771 | ) | (1) | $ | (696 | ) |
(3)
The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $(58) million and $(37) million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual for the three months ended September 30, 2018 and 2017, respectively.
The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $(10) million and $(91) million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual for the nine months ended September 30, 2018 and 2017, respectively.
Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third-party pricing service with observable inputs. Securities transferred to Level 3 represent securities with fair values that are now based on a single non-binding broker quote. The Company recognizes transfers between levels of the fair value hierarchy as of the beginning of the quarter in which each transfer occurred. For assets and liabilities held at the end of the reporting periods that are measured at fair value on a recurring basis, there were no transfers between Level 1 and Level 2.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:
|
| | | | | | | | | | | | | | | |
| September 30, 2018 |
Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average |
(in millions) |
Corporate debt securities (private placements) | $ | 949 | | Discounted cash flow | Yield/spread to U.S. Treasuries | 0.7 | % | - | 2.4% | 1.2 | % |
IUL embedded derivatives | $ | 684 | | Discounted cash flow | Nonperformance risk (1) | 83 bps | |
Indexed annuity embedded derivatives | $ | 11 | | Discounted cash flow | Surrender rate | 0.0 | % | - | 50.0% | |
| | | Nonperformance risk (1) | 83 bps | |
GMWB and GMAB embedded derivatives | $ | (686 | ) | Discounted cash flow | Utilization of guaranteed withdrawals (2) | 0.0 | % | - | 36.0% | |
| | | | Surrender rate | 0.1 | % | - | 73.4% | |
| | | | Market volatility (3) | 3.7 | % | - | 15.5% | |
| | | | Nonperformance risk (1) | 83 bps | |
|
| | | | | | | | | | | | | | | |
| December 31, 2017 |
Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average |
(in millions) |
Corporate debt securities (private placements) | $ | 1,070 | | Discounted cash flow | Yield/spread to U.S. Treasuries | 0.7 | % | - | 2.3% | 1.1 | % |
IUL embedded derivatives | $ | 601 | | Discounted cash flow | Nonperformance risk (1) | 71 bps | |
GMWB and GMAB embedded derivatives | $ | (49 | ) | Discounted cash flow | Utilization of guaranteed withdrawals (2) | 0.0 | % | - | 42.0% | |
| | | | Surrender rate | 0.1 | % | - | 74.7% | |
| | | | Market volatility (3) | 3.7 | % | - | 16.1% | |
| | | | Nonperformance risk (1) | 71 bps | |
Level 3 measurements not included in the table above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company.
Sensitivity of Fair Value Measurements to Changes in Unobservable Inputs
Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would result in a significantly lower (higher) fair value measurement.
Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would result in a significantly lower (higher) fair value measurement.
Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurement of the indexed annuity embedded derivatives in isolation would result in a significantly lower (higher) liability value.
Significant increases (decreases) in utilization and volatility used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would result in a significantly higher (lower) liability value. Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would result in a significantly lower (higher) liability value. Utilization of guaranteed withdrawals and surrender rates vary with the type of rider, the duration of the policy, the age of the contractholder, the distribution channel and whether the value of the guaranteed benefit exceeds the contract accumulation value.
Determination of Fair Value
The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy.
Assets
Cash Equivalents
Cash equivalents include highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less. The Company’s cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization.
Available-for-Sale Securities and Equity Securities
When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques. Level 1 securities includes U.S. Treasuries and equity securities. Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. Level 3 securities primarily include certain corporate bonds, non-agency residential mortgage backed securities and commercial mortgage backed securities. The fair value of corporate bonds, non-agency residential mortgage backed securities and commercial mortgage backed securities classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote. In addition to the general pricing controls, the Company reviews the broker prices to ensure that the broker quotes are reasonable and, when available, compares prices of privately issued securities to public issues from the same issuer to ensure that the implicit illiquidity premium applied to the privately placed investment is reasonable considering investment characteristics, maturity, and average life of the investment.
In consideration of the above, management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise.
Separate Account Assets
The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy.
Other Assets
Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The fair value of certain derivatives measured using pricing models which include significant unobservable inputs are classified as Level 3 within the fair value hierarchy. Other derivative contracts consist of the Company’s macro hedge derivatives that contain settlement provisions linked to both equity returns and interest rates. See Note 14 for further information on the macro hedge program. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial as of both September 30, 2018 and December 31, 2017. See Note 13 and Note 14 for further information on the credit risk of derivative instruments and related collateral.
Liabilities
Policyholder Account Balances, Future Policy Benefits and Claims
The Company values the embedded derivatives attributable to the provisions of certain variable annuity riders using internal valuation models. These models calculate fair value by discounting expected cash flows from benefits plus margins for profit, risk and expenses less embedded derivative fees. The projected cash flows used by these models include observable capital market assumptions and incorporate significant unobservable inputs related to contractholder behavior assumptions, implied volatility, and margins for risk, profit and expenses that the Company believes an exit market participant would expect. The fair value also reflects a current estimate
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
of the Company’s nonperformance risk specific to these embedded derivatives. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims.
The Company uses various Black-Scholes calculations to determine the fair value of the embedded derivatives associated with the provisions of its indexed annuity and IUL products. Significant inputs to the equity indexed annuity calculation include observable interest rates, volatilities and equity index levels and, therefore, are classified as Level 2. The fair value of fixed index annuity and IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company’s nonperformance risk. Given the significance of the nonperformance risk assumption to the fair value, the fixed index annuity and IUL embedded derivatives are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims.
The Company’s Corporate Actuarial Department calculates the fair value of the embedded derivatives on a monthly basis. During this process, control checks are performed to validate the completeness of the data. Actuarial management approves various components of the valuation along with the final results. The change in the fair value of the embedded derivatives is reviewed monthly with senior management. The Level 3 inputs into the valuation are consistent with the pricing assumptions and updated as experience develops. Significant unobservable inputs that reflect policyholder behavior are reviewed quarterly along with other valuation assumptions.
Other Liabilities
Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of both September 30, 2018 and December 31, 2017. See Note 13 and Note 14 for further information on the credit risk of derivative instruments and related collateral.
Fair Value on a Nonrecurring Basis
The Company assesses its investment in affordable housing partnerships for other-than-temporary impairment. The investments that are determined to be other-than-temporarily impaired are written down to their fair value. The Company uses a discounted cash flow model to measure the fair value of these investments. Inputs to the discounted cash flow model are estimates of future net operating losses and tax credits available to the Company and discount rates based on market condition and the financial strength of the syndicator (general partner). The balance of affordable housing partnerships measured at fair value on a nonrecurring basis was $132 million and $166 million as of September 30, 2018 and December 31, 2017, respectively, and is classified as Level 3 in the fair value hierarchy.
Asset and Liabilities Not Reported at Fair Value
The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:
|
| | | | | | | | | | | | | | | | | | | | |
| September 30, 2018 | |
Carrying Value | | Fair Value |
Level 1 | | Level 2 | | Level 3 | | Total |
(in millions) |
Financial Assets |
Mortgage loans, net | $ | 2,540 |
| | $ | — |
| | $ | — |
| | $ | 2,479 |
| | $ | 2,479 |
| |
Policy loans | 854 |
| | — |
| | — |
| | 805 |
| | 805 |
| |
Other investments | 407 |
| | — |
| | 384 |
| | 25 |
| | 409 |
| |
| | | | | | | | | | |
Financial Liabilities | | | | | | | | | | |
Policyholder account balances, future policy benefits and claims | $ | 9,786 |
| | $ | — |
| | $ | — |
| | $ | 9,846 |
| | $ | 9,846 |
| |
Short-term borrowings | 201 |
| | — |
| | 201 |
| | — |
| | 201 |
| |
Other liabilities | 75 |
| | — |
| | — |
| | 72 |
| | 72 |
| |
Separate account liabilities at NAV | 371 |
| | | | 371 |
| (1) |
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
|
| | | | | | | | | | | | | | | | | | | | |
| December 31, 2017 | |
Carrying Value | | Fair Value |
Level 1 | | Level 2 | | Level 3 | | Total |
(in millions) |
Financial Assets |
Mortgage loans, net | $ | 2,619 |
| | $ | — |
| | $ | — |
| | $ | 2,616 |
| | $ | 2,616 |
| |
Policy loans | 845 |
| | — |
| | — |
| | 801 |
| | 801 |
| |
Other investments | 408 |
| | — |
| | 373 |
| | 36 |
| | 409 |
| |
| | | | | | | | | | |
Financial Liabilities | | | | | | | | | | |
Policyholder account balances, future policy benefits and claims | $ | 10,246 |
| | $ | — |
| | $ | — |
| | $ | 10,755 |
| | $ | 10,755 |
| |
Short-term borrowings | 200 |
| | — |
| | 200 |
| | — |
| | 200 |
| |
Other liabilities | 123 |
| | — |
| | — |
| | 119 |
| | 119 |
| |
Separate account liabilities at NAV | 369 |
| | | | 369 |
| (1) |
See Note 6 for additional information on mortgage loans and policy loans. Other investments include syndicated loans and the Company’s membership in the FHLB. See Note 6 for additional information on syndicated loans.
Policyholder account balances, future policy benefit and claims includes fixed annuities in deferral status, non-life contingent fixed annuities in payout status, indexed annuity host contracts and the fixed portion of a small number of variable annuity contracts classified as investment contracts. See Note 8 for additional information on these liabilities. Short-term borrowings include include repurchase agreement and FHLB borrowings. See Note 10 for further information on short-term borrowings. Other liabilities include future funding commitments to affordable housing partnerships and other real estate partnerships. Separate account liabilities relate to investment contracts.
Insurance companies are required to prepare statutory financial statements in accordance with the accounting practices prescribed or permitted by the insurance departments of their respective states of domicile. RiverSource Life Insurance Company received approval from the Minnesota Department of Commerce to apply a permitted statutory accounting practice, effective July 1, 2017 through June 30, 2019, for certain derivative instruments used to economically hedge the interest rate exposure of certain variable annuity products that do not qualify for statutory hedge accounting. The permitted practice is intended to mitigate the impact to statutory surplus from the misalignment between variable annuity statutory reserves, which are not carried at fair value, and the fair value of derivatives used to economically hedge the interest rate exposure of non-life contingent living benefit guarantees. As of September 30, 2018 and December 31, 2017, application of this permitted practice resulted in an increase (decrease) to RiverSource Life Insurance Company’s statutory surplus of approximately $377 million and $(3) million, respectively.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
13. Offsetting Assets and Liabilities
Certain financial instruments and derivative instruments are eligible for offset in the Consolidated Balance Sheets. The Company’s derivative instruments and repurchase agreements are subject to master netting and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Consolidated Balance Sheets.
The following tables present the gross and net information about the Company’s assets subject to master netting arrangements:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | September 30, 2018 |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amounts of Assets Presented in the Consolidated Balance Sheets | | Gross Amounts Not Offset in the Consolidated Balance Sheets | | Net Amount |
| Financial Instruments (1) | | Cash Collateral | | Securities Collateral |
|
| (in millions) |
| Derivatives: | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| OTC | $ | 3,263 |
| | $ | — |
| | $ | 3,263 |
| | $ | (2,850 | ) | | $ | (396 | ) | | $ | (4 | ) | | $ | 13 |
|
| OTC cleared | 10 |
| | — |
| | 10 |
| | (9 | ) | | — |
| | — |
| | 1 |
|
| Exchange-traded | 17 |
| | — |
| | 17 |
| | (1 | ) | | — |
| | — |
| | 16 |
|
| Total derivatives | $ | 3,290 |
| | $ | — |
| | $ | 3,290 |
| | $ | (2,860 | ) | | $ | (396 | ) | | $ | (4 | ) | | $ | 30 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2017 |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amounts of Assets Presented in the Consolidated Balance Sheets | | Gross Amounts Not Offset in the Consolidated Balance Sheets | | Net Amount |
| Financial Instruments (1) | | Cash Collateral | | Securities Collateral |
|
| (in millions) |
| Derivatives: | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| OTC | $ | 3,440 |
| | $ | — |
| | $ | 3,440 |
| | $ | (2,599 | ) | | $ | (736 | ) | | $ | (88 | ) | | $ | 17 |
|
| OTC cleared | 21 |
| | — |
| | 21 |
| | (15 | ) | | — |
| | — |
| | 6 |
|
| Exchange-traded | 22 |
| | — |
| | 22 |
| | (1 | ) | | — |
| | — |
| | 21 |
|
| Total derivatives | $ | 3,483 |
| | $ | — |
| | $ | 3,483 |
| | $ | (2,615 | ) | | $ | (736 | ) | | $ | (88 | ) | | $ | 44 |
|
The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | September 30, 2018 |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amounts of Liabilities Presented in the Consolidated Balance Sheets | | Gross Amounts Not Offset in the Consolidated Balance Sheets | | Net Amount |
| Financial Instruments (1) | | Cash Collateral | | Securities Collateral |
|
| (in millions) |
| Derivatives: | | | | | | | | | | | | | |
| OTC | $ | 3,636 |
| | $ | — |
| | $ | 3,636 |
| | $ | (2,850 | ) | | $ | (44 | ) | | $ | (742 | ) | | $ | — |
|
| OTC cleared | 9 |
| | — |
| | 9 |
| | (9 | ) | | — |
| | — |
| | — |
|
| Exchange-traded | 2 |
| | — |
| | 2 |
| | (1 | ) | | — |
| | — |
| | 1 |
|
| Total derivatives | 3,647 |
|
| — |
|
| 3,647 |
|
| (2,860 | ) |
| (44 | ) |
| (742 | ) |
| 1 |
|
| Repurchase agreements | 51 |
| | — |
| | 51 |
| | — |
| | — |
| | (51 | ) | | — |
|
| Total | $ | 3,698 |
| | $ | — |
| | $ | 3,698 |
| | $ | (2,860 | ) | | $ | (44 | ) | | $ | (793 | ) | | $ | 1 |
|
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2017 |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Consolidated Balance Sheets | | Amounts of Liabilities Presented in the Consolidated Balance Sheets | | Gross Amounts Not Offset in the Consolidated Balance Sheets | | Net Amount |
| Financial Instruments (1) | | Cash Collateral | | Securities Collateral |
|
| (in millions) |
| Derivatives: | | | | | | | | | | | | | |
| OTC | $ | 3,095 |
| | $ | — |
| | $ | 3,095 |
| | $ | (2,599 | ) | | $ | (1 | ) | | $ | (492 | ) | | $ | 3 |
|
| OTC cleared | 15 |
| | — |
| | 15 |
| | (15 | ) | | — |
| | — |
| | — |
|
| Exchange-traded | 1 |
| | — |
| | 1 |
| | (1 | ) | | — |
| | — |
| | — |
|
| Total derivatives | 3,111 |
|
| — |
|
| 3,111 |
|
| (2,615 | ) |
| (1 | ) |
| (492 | ) |
| 3 |
|
| Repurchase agreements | 50 |
| | — |
| | 50 |
| | — |
| | — |
| | (50 | ) | | — |
|
| Total | $ | 3,161 |
| | $ | — |
| | $ | 3,161 |
| | $ | (2,615 | ) | | $ | (1 | ) | | $ | (542 | ) | | $ | 3 |
|
In the tables above, the amount of assets or liabilities presented are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables.
When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral.
Freestanding derivative instruments are reflected in other assets and other liabilities. Cash collateral pledged by the Company is reflected in other assets and cash collateral accepted by the Company is reflected in other liabilities. Repurchase agreements are reflected in short-term borrowings. See Note 14 for additional disclosures related to the Company’s derivative instruments and Note 10 for additional disclosures related to the Company’s repurchase agreements.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
14. Derivatives and Hedging Activities
Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations.
The Company’s freestanding derivative instruments are all subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Consolidated Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 13 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral.
The Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| September 30, 2018 | | December 31, 2017 |
Notional | | Gross Fair Value | Notional | | Gross Fair Value |
Assets (1) | | Liabilities (2) | Assets (1) | | Liabilities (2) |
(in millions) |
Derivatives not designated as hedging instruments | | | | | | | | | | | |
Interest rate contracts | $ | 58,424 |
| | $ | 609 |
| | $ | 602 |
| | $ | 64,790 |
| | $ | 1,081 |
| | $ | 415 |
|
Equity contracts | 53,666 |
| | 2,631 |
| | 3,018 |
| | 56,649 |
| | 2,367 |
| | 2,671 |
|
Credit contracts | 859 |
| | 7 |
| | — |
| | 715 |
| | — |
| | 2 |
|
Foreign exchange contracts | 4,141 |
| | 43 |
| | 27 |
| | 3,996 |
| | 35 |
| | 23 |
|
Other contracts | 1,349 |
| | — |
| | — |
| | 450 |
| | — |
| | — |
|
Total non-designated hedges | 118,439 |
| | 3,290 |
| | 3,647 |
| | 126,600 |
| | 3,483 |
| | 3,111 |
|
| | | | | | | | | | | |
Embedded derivatives | | | | | | | | | | | |
GMWB and GMAB (3) | N/A |
| | — |
| | (686 | ) | | N/A |
| | — |
| | (49 | ) |
IUL | N/A |
| | — |
| | 684 |
| | N/A |
| | — |
| | 601 |
|
Indexed annuities | N/A |
| | — |
| | 15 |
| | N/A |
| | — |
| | 5 |
|
Total embedded derivatives | N/A |
| | — |
| | 13 |
| | N/A |
| | — |
| | 557 |
|
Total derivatives | $ | 118,439 |
| | $ | 3,290 |
| | $ | 3,660 |
| | $ | 126,600 |
| | $ | 3,483 |
| | $ | 3,668 |
|
N/A Not applicable.
(1)
(2)
(3) of individual contracts in an asset position.
See Note 11 for additional information regarding the Company’s fair value measurement of derivative instruments.
As of September 30, 2018 and December 31, 2017, investment securities with a fair value of $5 million and $89 million, respectively, were received as collateral to meet contractual obligations under derivative contracts, of which $5 million and $89 million, respectively, may be sold, pledged or rehypothecated by the Company. As of both September 30, 2018 and December 31, 2017, the Company had sold, pledged, or rehypothecated nil of these securities. In addition, as of both September 30, 2018 and December 31, 2017, non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Consolidated Balance Sheets.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income:
|
| | | | | | | |
| Interest Credited to Fixed Accounts | | Benefits, Claims, Losses and Settlement Expenses |
(in millions) |
Three Months Ended September 30, 2018 | | | |
Interest rate contracts | $ | — |
| | $ | (206 | ) |
Equity contracts | 34 |
| | (210 | ) |
Credit contracts | — |
| | 4 |
|
Foreign exchange contracts | — |
| | — |
|
Other contracts | — |
| | (2 | ) |
GMWB and GMAB embedded derivatives | — |
| | 261 |
|
IUL embedded derivatives | (40 | ) | | — |
|
Total gain (loss) | $ | (6 | ) | | $ | (153 | ) |
|
| | | | | | | |
Nine Months Ended September 30, 2018 | | | |
Interest rate contracts | $ | — |
| | $ | (740 | ) |
Equity contracts | 37 |
| | (308 | ) |
Credit contracts | — |
| | 22 |
|
Foreign exchange contracts | — |
| | (1 | ) |
Other contracts | — |
| | (4 | ) |
GMWB and GMAB embedded derivatives | — |
| | 637 |
|
IUL embedded derivatives | (18 | ) | | — |
|
Total gain (loss) | $ | 19 |
| | $ | (394 | ) |
|
| | | | | | | |
| Interest Credited to Fixed Accounts | | Benefits, Claims, Losses and Settlement Expenses |
(in millions) |
Three Months Ended September 30, 2017 | | | |
Interest rate contracts | $ | — |
| | $ | 15 |
|
Equity contracts | 18 |
| | (241 | ) |
Credit contracts | — |
| | (3 | ) |
Foreign exchange contracts | — |
| | 1 |
|
Other contracts | — |
| | (2 | ) |
GMWB and GMAB embedded derivatives | — |
| | 227 |
|
IUL embedded derivatives | (24 | ) | | — |
|
Total gain (loss) | $ | (6 | ) | | $ | (3 | ) |
|
| | | | | | | |
Nine Months Ended September 30, 2017 | | | |
Interest rate contracts | $ | — |
| | $ | 63 |
|
Equity contracts | 50 |
| | (859 | ) |
Credit contracts | — |
| | (22 | ) |
Foreign exchange contracts | — |
| | (27 | ) |
Other contracts | — |
| | (2 | ) |
GMWB and GMAB embedded derivatives | — |
| | 569 |
|
IUL embedded derivatives | (43 | ) | | — |
|
Total gain (loss) | $ | 7 |
| | $ | (278 | ) |
The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The GMAB and non-life contingent GMWB provisions are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. The Company economically hedges the exposure related to GMAB and non-life contingent GMWB provisions using options (equity index, interest rate swaptions, etc.), swaps (interest rate, total return, etc.) and futures.
The deferred premium associated with certain of the above options and swaptions is paid or received semi-annually over the life of the contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options and swaptions as of September 30, 2018:
|
| | | | | | | | |
| Premiums Payable | | Premiums Receivable |
(in millions) |
2018 | (1) | $ | 51 |
| | $ | 31 |
|
2019 | 274 |
| | 169 |
|
2020 | 197 |
| | 130 |
|
2021 | 168 |
| | 118 |
|
2022 | 206 |
| | 198 |
|
2023-2026 | 494 |
| | 59 |
|
Total | $ | 1,390 |
| | $ | 705 |
|
(1) .
Actual timing and payment amounts may differ due to future settlements, modifications or exercises of the contracts prior to the full premium being paid or received.
The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. As a means of economically hedging these risks, the Company may use a combination of futures, options, swaps and swaptions. Certain of the macro hedge derivatives contain settlement provisions linked to both equity returns and interest rates. The Company’s macro hedge derivatives that contain settlement provisions linked to both equity returns and interest rates are shown in Other contracts in the tables above.
Indexed annuity and IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to indexed annuity and IUL products will positively or negatively impact earnings over the life of these products. The equity component of indexed annuity and IUL product obligations are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts.
Cash Flow Hedges
During the nine months ended September 30, 2018, the Company held no derivatives that were designated as cash flow hedges.
As of September 30, 2018, the Company expects to reclassify nil of deferred losses on derivative instruments from AOCI to earnings during the next 12 months that will be recorded in net investment income. These were originally losses on derivative instruments related to interest rate swaptions. During the nine months ended September 30, 2018 and 2017, no hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy. For the nine months ended September 30, 2018 and 2017, amounts recognized in earnings on derivative transactions that were ineffective were not material. See Note 15 for a summary of net unrealized gains (losses) included in AOCI related to previously designated cash flow hedges.
Currently, the longest period of time over which the Company is hedging exposure to the variability in future cash flows is less than one year and relates to interest credited on forecasted fixed premium product sales.
Credit Risk
Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting and collateral arrangements whenever practical. See Note 13 for additional information on the Company’s credit exposure related to derivative assets.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of the Company’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. As of September 30, 2018 and December 31, 2017, the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $409 million and $299 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of September 30, 2018 and December 31, 2017 was $409 million and $296 million, respectively. If the credit contingent provisions of derivative contracts in a net liability position as of September 30, 2018 and December 31, 2017 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been nil and $3 million, respectively.
15. Shareholder’s Equity
The following tables provide the amounts related to each component of OCI:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, |
2018 | | 2017 |
Pretax | Income Tax Benefit (Expense) | Net of Tax | Pretax | Income Tax Benefit (Expense) | Net of Tax |
(in millions) |
Net unrealized securities gains (losses): | | | | | | | | | | | |
Net unrealized securities gains (losses) arising during the period (1) | $ | (89 | ) | | $ | 19 |
| | $ | (70 | ) | | $ | 52 |
| | $ | (18 | ) | | $ | 34 |
|
Reclassification of net securities (gains) losses included in net income (2) | (4 | ) | | 1 |
| | (3 | ) | | (3 | ) | | 1 |
| | (2 | ) |
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables | 28 |
| | (6 | ) | | 22 |
| | (61 | ) | | 22 |
| | (39 | ) |
Net unrealized securities gains (losses) | (65 | ) | | 14 |
| | (51 | ) | | (12 | ) | | 5 |
| | (7 | ) |
Net unrealized derivatives gains (losses): | | | | | | | | | | | |
Reclassification of net derivative (gains) losses included in net income (3) | — |
| | — |
| | — |
| | 1 |
| | — |
| | 1 |
|
Net unrealized derivatives gains (losses) | — |
| | — |
| | — |
| | 1 |
| | — |
| | 1 |
|
Total other comprehensive income (loss) | $ | (65 | ) | | $ | 14 |
| | $ | (51 | ) | | $ | (11 | ) | | $ | 5 |
| | $ | (6 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, |
2018 | | 2017 |
Pretax | Income Tax Benefit (Expense) | Net of Tax | Pretax | Income Tax Benefit (Expense) | Net of Tax |
(in millions) |
Net unrealized securities gains (losses): | | | | | | | | | | | |
Net unrealized securities gains (losses) arising during the period (1) | $ | (832 | ) | | $ | 177 |
| | $ | (655 | ) | | $ | 245 |
| | $ | (85 | ) | | $ | 160 |
|
Reclassification of net securities (gains) losses included in net income (2) | (14 | ) | | 3 |
| | (11 | ) | | (34 | ) | | 12 |
| | (22 | ) |
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables | 347 |
| | (73 | ) | | 274 |
| | (168 | ) | | 59 |
| | (109 | ) |
Net unrealized securities gains (losses) | (499 | ) | | 107 |
| | (392 | ) | | 43 |
| | (14 | ) | | 29 |
|
Net unrealized derivatives gains (losses): | | | | | | | | | | | |
Reclassification of net derivative (gains) losses included in net income (3) | 1 |
| | — |
| | 1 |
| | 4 |
| | (1 | ) | | 3 |
|
Net unrealized derivatives gains (losses) | 1 |
| | — |
| | 1 |
| | 4 |
| | (1 | ) | | 3 |
|
Other | — |
| | — |
| | — |
| | (1 | ) | | — |
| | (1 | ) |
Total other comprehensive income (loss) | $ | (498 | ) | | $ | 107 |
| | $ | (391 | ) | | $ | 46 |
| | $ | (15 | ) | | $ | 31 |
|
(1)
(2)
(3)
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
Other comprehensive income (loss) related to net unrealized securities gains (losses) includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit other-than-temporary impairment losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.
The following tables present the changes in the balances of each component of AOCI, net of tax:
|
| | | | | | | | | | | | | | | |
| Net Unrealized Securities Gains | | Net Unrealized Derivatives Gains | | Other | | Total |
(in millions) |
Balance, July 1, 2018 | $ | 117 |
| | $ | — |
| | $ | (1 | ) | | $ | 116 |
|
OCI before reclassifications | (48 | ) | | — |
| | — |
| | (48 | ) |
Amounts reclassified from AOCI | (3 | ) | | — |
| | — |
| | (3 | ) |
Total OCI | (51 | ) | | — |
| | — |
| | (51 | ) |
Balance, September 30, 2018 | $ | 66 |
| (1) | $ | — |
| | $ | (1 | ) | | $ | 65 |
|
|
| | | | | | | | | | | | | | | |
Balance, January 1, 2018 | $ | 458 |
| | $ | (1 | ) | | $ | (1 | ) | | $ | 456 |
|
OCI before reclassifications | (381 | ) | | — |
| | — |
| | (381 | ) |
Amounts reclassified from AOCI | (11 | ) | | 1 |
| | — |
| | (10 | ) |
Total OCI | (392 | ) | | 1 |
| | — |
| | (391 | ) |
Balance, September 30, 2018 | $ | 66 |
| (1) | $ | — |
| | $ | (1 | ) | | $ | 65 |
|
|
| | | | | | | | | | | | | | | |
| Net Unrealized Securities Gains | | Net Unrealized Derivatives Gains | | Other | | Total |
(in millions) |
Balance, July 1, 2017 | $ | 497 |
| | $ | (2 | ) | | $ | (1 | ) | | $ | 494 |
|
OCI before reclassifications | (5 | ) | | — |
| | — |
| | (5 | ) |
Amounts reclassified from AOCI | (2 | ) | | 1 |
| | — |
| | (1 | ) |
Total OCI | (7 | ) | | 1 |
| | — |
| | (6 | ) |
Balance, September 30, 2017 | $ | 490 |
| (1) | $ | (1 | ) | | $ | (1 | ) | | $ | 488 |
|
|
| | | | | | | | | | | | | | | |
Balance, January 1, 2017 | $ | 461 |
| | $ | (4 | ) | | $ | — |
| | $ | 457 |
|
OCI before reclassifications | 51 |
| | — |
| | (1 | ) | | 50 |
|
Amounts reclassified from AOCI | (22 | ) | | 3 |
| | — |
| | (19 | ) |
Total OCI | 29 |
| | 3 |
| | (1 | ) | | 31 |
|
Balance, September 30, 2017 | $ | 490 |
| (1) | $ | (1 | ) | | $ | (1 | ) | | $ | 488 |
|
(1) nil and $2 million of noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities as of September 30, 2018 and September 30, 2017, respectively.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
16. Income Taxes
In December of 2017, the Tax Act reduced federal income tax rates from 35% to 21% for tax years after 2017. The Company’s effective tax rate was (4.2)% and 11.8% for the three months ended September 30, 2018 and 2017, respectively. The Company’s effective tax rate was 4.3% and 9.4% for the nine months ended September 30, 2018 and 2017, respectively.
The effective tax rate for the three months ended September 30, 2018 is lower than the statutory rate as a result of tax preferred items including low income housing tax credits, the dividends received deduction, an $8 million benefit related to the Internal Revenue Service’s (“IRS”) acceptance of a change in tax accounting method and foreign tax credits. The effective tax rate for the nine months ended September 30, 2018 is lower than the statutory rate as a result tax preferred items including low income housing tax credits, the dividends received deduction and foreign tax credits.
The effective tax rate for the three months ended September 30, 2017 was lower than the statutory rate as a result of tax preferred items including the dividends received deduction and low income housing tax credits. The effective tax rate for the nine months ended September 30, 2017 was lower than the statutory rate as a result of tax preferred items including the dividends received deduction and low income housing tax credits, as well as a $20 million benefit in the first quarter of 2017 related to an out-of-period correction for a reversal of a tax reserve.
The decrease in the effective tax rate for the three months ended September 30, 2018 compared to the prior period is primarily due to the reduced federal income tax rate, a decrease in pretax income and an $8 million benefit related to the IRS’s acceptance of a change in tax accounting method, partially offset by a decrease in the dividends received deduction.
The decrease in the effective tax rate for the nine months ended September 30, 2018 compared to the prior year period is primarily due to the reduced federal income tax rate and an increase in low income housing and foreign tax credits, partially offset by a decrease in the dividends received deduction and a $20 million benefit in the first quarter of 2017 related to an out-of-period correction for a reversal of a tax reserve.
As of December 31, 2017, the Company had not fully completed its accounting for the tax effects of the enactment of the Tax Act. However, the Company was able to provide reasonable estimates of the Tax Act’s impact; accordingly, the Company recorded a provisional tax amount of $136 million to remeasure certain deferred tax assets and liabilities as of December 31, 2017. In the third quarter of 2018, the Company finalized its accounting related to the Tax Act and determined no adjustment were necessary.
Included in the Company’s deferred income tax assets are tax benefits related to state net operating losses of $10 million, net of federal benefit, which will expire beginning December 31, 2018.
The Company is required to establish a valuation allowance for any portion of the deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established, and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination, (i) future taxable income exclusive of reversing temporary differences and carryforwards, (ii) future reversals of existing taxable temporary differences, (iii) taxable income in prior carryback years, and (iv) tax planning strategies. Based on analysis of the Company’s tax position, management believes it is more likely than not that the results of future operations and implementation of tax planning strategies will not allow the Company to realize certain state deferred tax assets and state net operating losses. The valuation allowance for state deferred tax assets and state net operating losses was $12 million and $11 million as of September 30, 2018 and December 31, 2017, respectively.
As of September 30, 2018 and December 31, 2017, the Company had $16 million and $14 million, respectively, of gross unrecognized tax benefits. If recognized, approximately $6 million and $5 million, net of federal tax benefits, of unrecognized tax benefits as of September 30, 2018 and December 31, 2017, respectively, would affect the effective tax rate.
It is reasonably possible that the total amount of unrecognized tax benefits will change in the next 12 months. Based on the current audit position of the Company, it is estimated that the total amount of gross unrecognized tax benefits may decrease by approximately $10 million in the next 12 months primarily due to resolution of audits and statute expirations.
The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized nil in interest and penalties for both the three months and nine months ended September 30, 2018. The Company recognized a net increase (decrease) of $(1) million and $1 million in interest and penalties for the three months and nine months ended September 30, 2017, respectively. As of both September 30, 2018 and December 31, 2017, the Company had a payable of $1 million related to accrued interest and penalties.
The Company files income tax returns as part of its inclusion in the consolidated federal income tax returns of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. In the first quarter of 2018, the Company received cash settlements for final resolution of the 2008 through 2010 IRS audits. In the third quarter of 2018, Ameriprise Financial reached an agreement with IRS appeals to resolve the 2012 and 2013 audit. Accordingly, Ameriprise Financial’s IRS audits are effectively settled through 2013. The IRS is currently auditing Ameriprise Financial’s U.S. income tax returns for 2014 and 2015. Ameriprise Financial’s or the Company’s state income tax returns are currently under examination by various jurisdictions for years ranging from 2009 through 2016.
RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)
17. Contingencies
Insurance companies have been the subject of increasing regulatory, legislative and judicial scrutiny. Numerous state and federal regulatory agencies have commenced examinations and other inquiries of insurance companies regarding sales and marketing practices (including sales to older consumers and disclosure practices), claims handling, and unclaimed property and escheatment practices and procedures. The Company has cooperated and will continue to cooperate with the applicable regulators.
The Company is involved in the normal course of business in a number of other legal and arbitration proceedings concerning matters arising in connection with the conduct of its business activities. The Company believes that it is not a party to, nor are any of its properties the subject of, any pending legal, arbitration or regulatory investigation, examination or proceeding that is likely to have a material adverse effect on its consolidated financial condition, results of operations or liquidity. Notwithstanding the foregoing, it is possible that the outcome of any current or future legal, arbitration or regulatory proceeding could have a material impact on results of operations in any particular reporting period as the proceedings are resolved.
Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally.
RiverSource Life Insurance Company and RiverSource Life of NY are required by law to be a member of the guaranty fund association in every state where they are licensed to do business. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund associations.
The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations (“NOLHGA”) and the amount of its premiums written relative to the industry-wide premium in each state. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated.
The Company has a liability for estimated guaranty fund assessments and a related premium tax asset. As of September 30, 2018 and December 31, 2017, the estimated liability was $13 million and $14 million, respectively. As of both September 30, 2018 and December 31, 2017, the related premium tax asset was $12 million. The expected period over which guaranty fund assessments will be made and the related tax credits recovered is not known.
RIVERSOURCE LIFE INSURANCE COMPANY
ITEM 2. MANAGEMENT’S NARRATIVE ANALYSIS
Overview
RiverSource Life Insurance Company and its subsidiaries are referred to collectively in this Form 10-Q as the “Company”. The following discussion and management’s narrative analysis of the financial condition and results of operations should be read in conjunction with the “Forward-Looking Statements” that follow, the Consolidated Financial Statements and Notes presented in Item 1 and its Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission (“SEC”) on February 22, 2018 (“2017 10-K”), as well as any current reports on Form 8-K and other publicly available information.
The Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Management’s narrative analysis is presented pursuant to General Instructions H(2)(a) of Form 10-Q in lieu of Management’s Discussion and Analysis of Financial Condition and Results of Operations.
See Note 1 to the Consolidated Financial Statements for additional information.
Critical Accounting Estimates
The accounting and reporting policies that the Company uses affect its Consolidated Financial Statements. Certain of the Company’s accounting and reporting policies are critical to an understanding of the Company’s financial condition and results of operations. In some cases, the application of these policies can be significantly affected by the estimates, judgments and assumptions made by management during the preparation of the Consolidated Financial Statements. These accounting policies are discussed in detail in “Management’s Narrative Analysis — Critical Accounting Estimates” in the Company’s 2017 10-K.
Recent Accounting Pronouncements
For information regarding recent accounting pronouncements and their expected impact on the Company’s future consolidated financial condition or results of operations, see Note 2 to the Consolidated Financial Statements.
Consolidated Results of Operations for the Nine Months Ended September 30, 2018 and 2017
The following table presents the Company’s consolidated results of operations:
|
| | | | | | | | | | | | | | |
| Nine Months Ended September 30, | | Change |
2018 | | 2017 |
(in millions) | | |
Revenues | | | | | | | |
Premiums | $ | 296 |
| | $ | 304 |
| | $ | (8 | ) | | (3 | )% |
Net investment income | 757 |
| | 797 |
| | (40 | ) | | (5 | ) |
Policy and contract charges | 1,579 |
| | 1,427 |
| | 152 |
| | 11 |
|
Other revenues | 313 |
| | 296 |
| | 17 |
| | 6 |
|
Net realized investment gains | 14 |
| | 31 |
| | (17 | ) | | (55 | ) |
Total revenues | 2,959 |
| | 2,855 |
| | 104 |
| | 4 |
|
| | | | | | | |
Benefits and expenses | | | | | | | |
Benefits, claims, losses and settlement expenses | 1,134 |
| | 920 |
| | 214 |
| | 23 |
|
Interest credited to fixed accounts | 499 |
| | 509 |
| | (10 | ) | | (2 | ) |
Amortization of deferred acquisition costs | 133 |
| | 142 |
| | (9 | ) | | (6 | ) |
Other insurance and operating expenses | 512 |
| | 527 |
| | (15 | ) | | (3 | ) |
Total benefits and expenses | 2,278 |
| | 2,098 |
| | 180 |
| | 9 |
|
Pretax income | 681 |
| | 757 |
| | (76 | ) | | (10 | ) |
Income tax provision | 29 |
| | 71 |
| | (42 | ) | | (59 | ) |
Net income | $ | 652 |
| | $ | 686 |
| | $ | (34 | ) | | (5 | )% |
NM Not Meaningful. |
Overall
Net income decreased $34 million or 5% to $652 million for the nine months ended September 30, 2018 compared to $686 million for the prior year period. Pretax income decreased $76 million or 10% to $681 million for the nine months ended September 30, 2018 compared to $757 million for the prior year period primarily reflecting the impact of unlocking, partially offset by equity market appreciation.
In the third quarter of the year, management updated its market-related inputs and implemented model changes related to the living benefit valuation. In addition, management conducted its annual review of insurance and annuity valuation assumptions relative to
RIVERSOURCE LIFE INSURANCE COMPANY
current experience and management expectations including modeling changes. These aforementioned changes are collectively referred to as unlocking. Management also reviewed its active life future policy benefit reserve adequacy for its long term care (“LTC”) business in the third quarter.
The following table presents the total pretax impacts on the Company’s revenues and expenses attributable to unlocking and LTC loss recognition for the nine months ended September 30:
|
| | | | | | | | |
Pretax Increase (Decrease) | | 2018 | | 2017 |
| | (in millions) |
Policy and contract charges | | $ | 78 |
| | $ | (47 | ) |
Total revenues | | 78 |
| | (47 | ) |
| | | | |
Benefits, claims, losses and settlement expenses: | | | | |
LTC loss recognition | | 51 |
| | 57 |
|
Unlocking impact | | 113 |
| | (139 | ) |
Total benefits, claims, losses and settlement expenses | | 164 |
| | (82 | ) |
Amortization of deferred acquisition costs | | (33 | ) | | (12 | ) |
Total benefits and expenses | | 131 |
| | (94 | ) |
Pretax income | | $ | (53 | ) | | $ | 47 |
|
The following market impacts were significant drivers of the period-over-period change in pretax income:
| |
• | The impact on deferred acquisition costs (“DAC”), deferred sales inducement costs (“DSIC”) and reserves for insurance features in non-traditional long-duration contracts from actual versus expected market performance was a benefit of $39 million ($12 million for DAC, $3 million for DSIC and $24 million for insurance features in non-traditional long-duration contracts) for the nine months ended September 30, 2018 compared to a benefit of $63 million ($27 million for DAC, $6 million for DSIC and $30 million for insurance features in non-traditional long-duration contracts) for the prior year period. |
| |
• | The market impact on variable annuity guaranteed benefits (net of hedges and the related DSIC and DAC amortization) was an expense of $102 million for the nine months ended September 30, 2018 compared to an expense of $142 million for the prior year period. |
| |
• | The market impact on indexed universal life benefits (net of hedges and the related DAC amortization, unearned revenue amortization and the reinsurance accrual) was an expense of $8 million for the nine months ended September 30, 2018 compared to an expense of $16 million for the prior year period. |
The Company’s variable annuity account balances increased 1% to $79.4 billion as of September 30, 2018 compared to the prior year period due to equity market appreciation, partially offset by net outflows of $3.4 billion.
The Company’s fixed deferred annuity account balances declined 7% to $8.9 billion as of September 30, 2018 compared to the prior year period as older policies continue to lapse and new sales are limited due to low interest rates. Given the current interest rate environment, the Company’s current fixed deferred annuity book is expected to gradually run off and earnings on its fixed deferred annuity business will trend down.
Revenues
Net investment income decreased $40 million or 5% to $757 million for the nine months ended September 30, 2018 compared to $797 million for the prior year period reflecting a decrease in investment income on fixed maturities due to lower average invested assets and continued low interest rates.
Policy and contract charges increased $152 million or 11% to $1.6 billion for the nine months ended September 30, 2018 compared to $1.4 billion for the prior year period primarily due to the impact of unlocking and an increase in variable annuity guaranteed benefit rider charges driven by higher average fee rates on variable annuity guarantee sales and sales in the prior year where the fees start on the first anniversary date, partially offset by a $10 million expense related to a modification of costs within a reinsurance contract. Policy and contract charges for the nine months ended September 30, 2018 included a $78 million favorable impact from unlocking compared to a $47 million unfavorable impact in the prior year period. The primary driver of the unlocking impact to policy and contract charges for the nine months ended September 30, 2018 was higher projected gains on reinsurance contracts resulting from unfavorable mortality experience on universal life (“UL”) and variable universal life (“VUL”) insurance products. The primary driver of the unlocking impact to policy and contract charges for the prior year period was lower projected gains on reinsurance contracts resulting from favorable mortality experience on UL and VUL insurance products.
Other revenues increased $17 million or 6% to $313 million for the nine months ended September 30, 2018 compared to $296 million for the prior year period due to higher fees on variable annuities driven by higher average separate account balances. Average variable annuity account balances increased $2.6 billion or 4% from the prior year period due to equity market appreciation partially offset by net outflows.
RIVERSOURCE LIFE INSURANCE COMPANY
Net realized investment gains were $14 million for the nine months ended September 30, 2018 compared to $31 million for the prior year period. For the nine months ended September 30, 2018, net realized gains on Available-for-Sale securities due to sales, calls and tenders were $14 million. For the nine months ended September 30, 2017, net realized gains on Available-for-Sale securities due to sales, calls and tenders were $34 million partially offset by a loss of $4 million related to the intent to sell residential mortgage loans.
Benefits and Expenses
Benefits, claims, losses and settlement expenses increased $214 million or 23% to $1.1 billion for the nine months ended September 30, 2018 compared to $920 million for the prior year period primarily reflecting the following items:
| |
• | The nine months ended September 30, 2018 included a $113 million expense from unlocking compared to a $139 million benefit in the prior year period. The unlocking impact for the third quarter of 2018 primarily reflected unfavorable mortality experience on UL and VUL insurance products and lower surrender rate assumptions on variable annuities, partially offset by a favorable impact from updates to assumptions on utilization of guaranteed withdrawal benefits. The unlocking impact for the third quarter of 2017 primarily reflected a benefit from updates to market-related inputs to the living benefit valuation. |
| |
• | An $18 million increase in expense related to higher reserve funding driven by the impact of higher variable annuity guaranteed benefit rider charges. |
| |
• | The impact on DSIC and reserves for insurance features in non-traditional long-duration contracts from actual versus expected market performance was a benefit of $27 million for the nine months ended September 30, 2018 compared to a benefit of $36 million for the prior year period. |
| |
• | A $51 million expense from loss recognition on LTC insurance products in the third quarter of 2018 compared to a $57 million expense in the third quarter of 2017. The loss recognition in both periods was primarily due to unfavorable morbidity experience, partially offset by approved, pending and future expected premium increases. |
| |
• | A $62 million decrease in expense from the unhedged nonperformance credit spread risk adjustment on variable annuity guaranteed benefits. The unfavorable impact of the nonperformance credit spread was $60 million for the nine months ended September 30, 2018 compared to an unfavorable impact of $122 million for the prior year period. As the estimate of the nonperformance credit spread over the LIBOR swap curve tightens or widens, the embedded derivative liability will increase or decrease. As the embedded derivative liability on which the nonperformance credit spread is applied increases (decreases), the impact of the nonperformance credit spread is favorable (unfavorable) to expense. |
| |
• | A $16 million increase in expense from other market impacts on variable annuity guaranteed benefits, net of hedges in place to offset those risks and the related DSIC amortization. This increase was the result of an unfavorable $186 million change in the market impact on derivatives hedging the variable annuity guaranteed benefits, a favorable $174 million change in the market impact on variable annuity guaranteed living benefits reserves, and an unfavorable $4 million change in the DSIC offset. The main market drivers contributing to these changes are summarized below: |
| |
• | Equity market impact on the variable annuity guaranteed living benefits liability net of the impact on the corresponding hedge assets resulted in an expense for the nine months ended September 30, 2018 compared to a benefit for the prior year period. |
| |
• | Interest rate impact on the variable annuity guaranteed living benefits liability net of the impact on the corresponding hedge assets resulted in a benefit for the nine months ended September 30, 2018 compared to an expense in the prior year period. |
| |
• | Volatility impact on the variable annuity guaranteed living benefits liability net of the impact on the corresponding hedge assets resulted in a lower expense for the nine months ended September 30, 2018 compared to the prior year period. |
| |
• | Other unhedged items, including the difference between the assumed and actual underlying separate account investment performance, fixed income credit exposures, transaction costs and various behavioral items, were a net unfavorable impact compared to the prior year period. |
| |
• | A $15 million decrease in disability income claims, partially offset by a $4 million increase in life claims. |
Amortization of DAC decreased $9 million or 6% to $133 million for the nine months ended September 30, 2018 compared to $142 million for the prior year period primarily reflecting the following items:
| |
• | The impact of unlocking was a benefit of $33 million for the nine months ended September 30, 2018 compared to a benefit of $12 million for the prior year period. The impact of unlocking in the third quarter of 2018 primarily reflected updated mortality assumptions on UL and VUL insurance products and lower surrender rate assumptions on variable annuities, partially offset by an unfavorable impact from updates to assumptions on utilization of guaranteed withdrawal benefits. The impact of unlocking in the third quarter of 2017 primarily reflected improved persistency and mortality on UL and VUL insurance products and a $10 million benefit from a correction related to a variable annuity model assumption, partially offset by updates to market-related inputs to the living benefit valuation. |
| |
• | The DAC offset to the market impact on variable annuity guaranteed benefits (net of hedges and the related DSIC amortization) was a benefit of $9 million for the nine months ended September 30, 2018 compared to a benefit of $18 million for the prior year period. |
| |
• | The impact on DAC from actual versus expected market performance was a benefit of $12 million for the nine months ended September 30, 2018 compared to a benefit of $27 million for the prior year period. |
| |
• | The positive impact on DAC from lower than expected lapses on variable annuities was $7 million. |
RIVERSOURCE LIFE INSURANCE COMPANY
Income Taxes
The Company’s effective tax rate was 4.3% for the nine months ended September 30, 2018 compared to 9.4% for the prior year period. See Note 16 to the Consolidated Financial Statements for additional discussion on income taxes.
Market Risk
The Company’s primary market risk exposures are interest rate, equity price and credit risk. Equity price and interest rate fluctuations can have a significant impact on the Company’s results of operations, primarily due to the effects on asset-based fees and expenses, the “spread” income generated on its fixed deferred annuities, fixed insurance and the fixed portion of its variable annuities and variable insurance contracts, the value of DAC and DSIC assets, the value of liabilities for guaranteed benefits associated with its variable annuities and the value of derivatives held to hedge these benefits.
The Company’s earnings from fixed deferred annuities, fixed insurance, and the fixed portion of variable annuities and variable insurance contracts are based upon the spread between rates earned on assets held and the rates at which interest is credited to accounts. The Company primarily invests in fixed rate securities to fund the rate credited to clients. The Company guarantees an interest rate to the holders of these products. Investment assets and client liabilities generally differ as it relates to basis, repricing or maturity characteristics. Rates credited to clients’ accounts generally reset at shorter intervals than the yield on the underlying investments. Therefore, in an increasing interest rate environment, higher interest rates may be reflected in crediting rates to clients sooner than in rates earned on invested assets, which could result in a reduced spread between the two rates, reduced earned income and a negative impact on pretax income. However, the current low interest rate environment is resulting in interest rates below the level of some of the Company’s liability guaranteed minimum interest rates (“GMIRs”). Hence, a modest rise in interest rates would not necessarily result in changes to all the liability credited rates while projected asset purchases would capture the full increase in interest rates. This dynamic would result in widening spreads under a modestly rising rate scenario given the current relationship between the current level of interest rates and the underlying GMIRs on the business.
As a result of the low interest rate environment, the Company’s current reinvestment yields are generally lower than the current portfolio yield. The Company expects its portfolio income yields to continue to decline in future periods if interest rates remain low. The carrying value and weighted average yield of total non-structured fixed maturity securities and commercial mortgage loans in the Company’s investment portfolio that may generate proceeds to reinvest through September 30, 2020 due to prepayment, maturity or call activity at the option of the issuer, excluding securities with a make-whole provision, were $2.5 billion and 5.2%, respectively, as of September 30, 2018. In addition, residential mortgage-backed securities, which are subject to prepayment risk as a result of the low interest rate environment, totaled $2.9 billion and had a weighted average yield of 3.4% as of September 30, 2018. While these amounts represent investments that could be subject to reinvestment risk, it is also possible that these investments will be used to fund liabilities or may not be prepaid and will remain invested at their current yields. In addition to the interest rate environment, the mix of benefit payments versus product sales as well as the timing and volumes associated with such mix may impact the Company’s investment yield. Furthermore, reinvestment activities and the associated investment yield may also be impacted by corporate strategies implemented at management’s discretion. The average yield for investment purchases during the nine months ended September 30, 2018 was approximately 4.1%.
The reinvestment of proceeds from maturities, calls and prepayments at rates below the current portfolio yield, which may be below the level of some liability GMIRs, will have a negative impact to future operating results. To mitigate the unfavorable impact that the low interest rate environment has on the Company’s spread income, it assesses reinvestment risk in its investment portfolio and monitors this risk in accordance with its asset/liability management framework. In addition, the Company may reduce the crediting rates on its fixed products when warranted, subject to guaranteed minimums.
In addition to the fixed rate exposures noted above, the Company also has the following variable annuity guarantee benefits: guaranteed minimum withdrawal benefits (“GMWB”), guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum death benefits (“GMDB”) and guaranteed minimum income benefits (“GMIB”). Each of these benefits guarantees payouts to the annuity holder under certain specific conditions regardless of the performance of the underlying invested assets.
The variable annuity guarantees continue to be managed by utilizing a hedging program which attempts to match the sensitivity of the assets with the sensitivity of the liabilities. This approach works with the premise that matched sensitivities will produce a highly effective hedging result. The Company’s comprehensive hedging program focuses mainly on first order sensitivities of assets and liabilities: Equity Market Level (Delta), Interest Rate Level (Rho) and Volatility (Vega). Additionally, various second order sensitivities are managed. The Company uses various options (equity index, interest rate swaptions, etc.), swaps (interest rate, total return, etc.) and futures to manage risk exposures. The exposures are measured and monitored daily and adjustments to the hedge portfolio are made as necessary.
The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. The Company assesses this residual risk under a range of scenarios in creating and executing the macro hedge program. As a means of economically hedging these risks, the Company may use a combination of futures, options, swaps and swaptions. Certain of the macro hedge derivatives used contain settlement provisions linked to both equity returns and interest rates; the remaining are interest rate contracts or equity contracts. The macro hedge program could result in additional earnings volatility as changes in the value of the macro hedge
RIVERSOURCE LIFE INSURANCE COMPANY
derivatives, which are designed to reduce statutory capital volatility, may not be closely aligned to changes in the variable annuity guarantee embedded derivatives.
To evaluate interest rate and equity price risk, the Company performs sensitivity testing which measures the impact on pretax income from the sources listed below for a 12-month period following a hypothetical 100 basis point increase in interest rates or a hypothetical 10% decline in equity prices. The interest rate risk test assumes a sudden 100 basis point parallel shift in the yield curve, with rates then staying at those levels for the next 12 months. The equity price risk test assumes a sudden 10% drop in equity prices, with equity prices then staying at those levels for the next 12 months. In estimating the values of variable annuity riders, indexed annuities, indexed universal life insurance and the associated hedge assets, the Company assumed no change in implied market volatility despite the 10% drop in equity prices.
The following tables present the Company’s estimate of the impact on pretax income from the above defined hypothetical market movements as of September 30, 2018:
|
| | | | | | | | | | | | |
Equity Price Decline 10% | | Equity Price Exposure to Pretax Income |
Before Hedge Impact | Hedge Impact | Net Impact |
| | (in millions) |
Asset-based fees and expenses | | $ | (88 | ) | | $ | — |
| | $ | (88 | ) |
DAC and DSIC amortization (1) (2) | | (123 | ) | | — |
| | (123 | ) |
Variable annuity riders: | | |
| | |
| | |
GMDB and GMIB (2) | | (29 | ) | | — |
| | (29 | ) |
GMWB | | (373 | ) | | 231 |
| | (142 | ) |
GMAB | | (16 | ) | | 17 |
| | 1 |
|
DAC and DSIC amortization (3) | | N/A |
| | N/A |
| | (8 | ) |
Total variable annuity riders | | (418 | ) |
| 248 |
|
| (178 | ) |
Macro hedge program (4) | | — |
| | 24 |
| | 24 |
|
Indexed annuities | | 2 |
| | (2 | ) | | — |
|
Indexed universal life insurance | | 76 |
| | (72 | ) | | 4 |
|
Total | | $ | (551 | ) |
| $ | 198 |
|
| $ | (361 | ) |
|
| | | | | | | | | | | | |
Interest Rate Increase 100 Basis Points | | Interest Rate Exposure to Pretax Income |
Before Hedge Impact | Hedge Impact | Net Impact |
| | (in millions) |
Asset-based fees and expenses | | $ | (31 | ) | | $ | — |
| | $ | (31 | ) |
Variable annuity riders: | | |
| | |
| | |
|
GMDB and GMIB | | — |
| | — |
| | — |
|
GMWB | | 766 |
| | (532 | ) | | 234 |
|
GMAB | | 14 |
| | (9 | ) | | 5 |
|
DAC and DSIC amortization (3) | | N/A |
| | N/A |
| | (36 | ) |
Total variable annuity riders | | 780 |
|
| (541 | ) |
| 203 |
|
Macro hedge program (4) | | — |
| | (1 | ) | | (1 | ) |
Indexed annuities | | — |
| | — |
| | — |
|
Fixed annuities, fixed insurance and fixed portion of variable annuities and variable insurance products | | 65 |
| | — |
| | 65 |
|
Indexed universal life insurance | | 121 |
| | 3 |
| | 124 |
|
Total | | $ | 935 |
|
| $ | (539 | ) |
| $ | 360 |
|
N/A Not Applicable.
| |
(1) | Market impact on DAC and DSIC amortization resulting from lower projected profits. |
| |
(2) | In estimating the impact on DAC and DSIC amortization resulting from lower projected profits, the Company has not changed its assumed equity asset growth rates. This is a significantly more conservative estimate than if the Company assumed management follows its mean reversion guideline and increased near-term rates to recover the drop in equity values over a five-year period. The Company makes this same conservative assumption in estimating the impact from GMDB and GMIB riders and the life contingent benefits associated with GMWB. |
| |
(3) | Market impact on DAC and DSIC amortization related to variable annuity riders is modeled net of hedge impact. |
| |
(4) | The market impact of the macro hedge program is modeled net of any related impact to DAC and DSIC amortization. |
RIVERSOURCE LIFE INSURANCE COMPANY
The above results compare to an estimated negative net impact to pretax income of $399 million related to a 10% equity price decline and an estimated positive net impact to pretax income of $97 million related to a 100 basis point increase in interest rates as of December 31, 2017. The change in interest rate exposure was driven by variable annuity riders primarily due to changes in market rates.
Net impacts shown in the above table from GMWB riders result largely from differences between the liability valuation basis and the hedging basis. Liabilities are valued using fair value accounting principles, with risk margins incorporated in contractholder behavior assumptions and with discount rates increased to reflect a current market estimate of the Company’s risk of nonperformance specific to these liabilities. The Company’s hedging is based on its determination of economic risk, which excludes certain items in the liability valuation including the nonperformance spread risk.
Actual results could differ materially from those illustrated above as they are based on a number of estimates and assumptions. These include assuming that implied market volatility does not change when equity prices fall by 10%, that management does not increase assumed equity asset growth rates to anticipate recovery of the drop in equity values when valuing DAC, DSIC and the liability values associated with GMDB, GMIB and the life contingent benefits associated with GMWB; and that the 100 basis point increase in interest rates is a parallel shift of the yield curve. Furthermore, the Company has not tried to anticipate changes in client preferences for different types of assets or other changes in client behavior, nor has the Company tried to anticipate actions management might take to increase revenues or reduce expenses in these scenarios.
The selection of a 100 basis point interest rate increase as well as a 10% equity price decline should not be construed as a prediction of future market events. Impacts of larger or smaller changes in interest rates or equity prices may not be proportional to those shown for a 100 basis point increase in interest rates or a 10% decline in equity prices.
Fair Value Measurements
The Company reports certain assets and liabilities at fair value; specifically, separate account assets, derivatives, embedded derivatives, most investments and cash equivalents. Fair value assumes the exchange of assets or liabilities occurs in orderly transactions and is not the result of a forced liquidation or distressed sale. The Company includes actual market prices, or observable inputs, in its fair value measurements to the extent available. Broker quotes are obtained when quotes from pricing services are not available. The Company validates prices obtained from third parties through a variety of means such as: price variance analysis, subsequent sales testing, stale price review, price comparison across pricing vendors and due diligence reviews of vendors. See Note 11 to the Consolidated Financial Statements for additional information on the Company’s fair value measurements.
Fair Value of Liabilities and Nonperformance Risk
Companies are required to measure the fair value of liabilities at the price that would be received to transfer the liability to a market participant (an exit price). Since there is not a market for the Company’s obligations of its variable annuity riders, indexed annuities and indexed universal life insurance, the Company considers the assumptions participants in a hypothetical market would make to reflect an exit price. As a result, the Company adjusts the valuation of variable annuity riders, indexed annuities and indexed universal life insurance by updating certain contractholder assumptions, adding explicit margins to provide for profit, risk and expenses, and adjusting the rates used to discount expected cash flows to reflect a current market estimate of the Company’s nonperformance risk. The nonperformance risk adjustment is based on observable market data adjusted to estimate the risk of the Company not fulfilling these liabilities. Consistent with general market conditions, this estimate resulted in a spread over the LIBOR swap curve as of September 30, 2018. As the Company’s estimate of this spread widens or tightens, the liability will decrease or increase. If this nonperformance credit spread moves to a zero spread over the LIBOR swap curve, the reduction to future net income would be approximately $261 million, net of DAC, DSIC, unearned revenue amortization, the reinsurance accrual and income taxes (calculated at the statutory tax rate of 21%), based on September 30, 2018 credit spreads.
Liquidity and Capital Resources
Liquidity Strategy
The liquidity requirements of the Company are generally met by funds provided by investment income, maturities and periodic repayments of investments, premiums and proceeds from sales of investments, fixed annuity and fixed insurance deposits as well as capital contributions from its parent, Ameriprise Financial, Inc. (“Ameriprise Financial”). Other liquidity sources the Company has established are short-term borrowings and available lines of credit with Ameriprise Financial aggregating $996 million.
The Company enters into short-term borrowings, which may include repurchase agreements and Federal Home Loan Bank (“FHLB”) advances to reduce reinvestment risk. Short-term borrowings allow the Company to receive cash to reinvest in longer-duration assets, while paying back the short-term debt with cash flows generated by the fixed income portfolio. The balance of repurchase agreements as of both September 30, 2018 and December 31, 2017 was $50 million, which is collateralized with agency residential mortgage backed securities and commercial mortgage backed securities from the Company’s investment portfolio. RiverSource Life Insurance Company is a member of the FHLB of Des Moines, which provides RiverSource Life Insurance Company access to collateralized borrowings. As of September 30, 2018, the Company had estimated maximum borrowing capacity of $5.9 billion under the FHLB facility, of which $151 million was outstanding and is collateralized with commercial mortgage backed securities.
RIVERSOURCE LIFE INSURANCE COMPANY
The primary uses of funds are policy benefits, commissions, other product-related acquisition and sales inducement costs, operating expenses, policy loans, dividends to Ameriprise Financial and investment purchases. The Company routinely reviews its sources and uses of funds in order to meet its ongoing obligations.
In 2009, the Company established an agreement to protect its exposure to Genworth Life Insurance Company (“GLIC”) for its reinsured LTC. In 2016, substantial enhancements to this reinsurance protection agreement were finalized. The terms of these confidential provisions within the agreement have been shared, in the normal course of regular reviews, with the Company’s domiciliary regulator and rating agencies. Management believes that this agreement and offsetting non LTC legacy arrangements with Genworth will enable the Company to recover on all net exposure in the event of an insolvency of GLIC.
The Company’s LTC insurance has two distinct blocks. The Company’s older generation nursing home indemnity LTC policies were written between 1989 and 1999 and represent half of its policies. As of September 30, 2018, this block had approximately $90 million in gross in-force annual premium and future policyholder benefits and claim reserves of $1.3 billion, net of reinsurance, which was 56% of GAAP reserves. This block has been shrinking over the last few years given the average attained age is 81 and the average attained age of policyholders on claim is 87. Fifty-five percent of the policies in this block have lifetime benefits.
The Company’s second generation comprehensive reimbursement LTC polices were written from 1997 until 2002. This block has higher premiums per policy than the nursing home indemnity LTC policies. Thirty-eight percent of the policies in this block have lifetime benefits. The average attained age is 75 overall and the average age of those on claim is 83 for this block. As of September 30, 2018, this block had approximately $116 million in gross in-force annual premium and future policyholder benefits and claim reserves of $1.0 billion, net of reinsurance.
The Company utilizes three primary levers to manage its LTC business. First, the Company has taken an active approach to steadily increasing rates since 2005, with cumulative rate increases of 139% on its nursing home indemnity LTC block and 64% on its comprehensive reimbursement LTC block. Second, the Company has a reserving process that reflects the policy features and risk characteristics of its blocks. As of December 31, 2017, the Company had 29,000 policies that were closed with claim activity, as well as 8,000 open claims. The Company applies this experience to its in-force policies, which were 112,000 as of December 31, 2017, at a very granular level by issue year, attained age and benefit features. The Company’s statutory reserves are approximately $370 million higher than its GAAP reserves and includes margins for key assumptions like morbidity and mortality, as well as $180 million in asset adequacy reserves. Lastly, the Company has prudently managed its investment portfolio by maintaining a liquid, investment grade portfolio that is currently in a net unrealized gain position.
Further discussion of the Company’s LTC business and review process of reserves is included in its 2017 10-K.
Capital Activity
Dividends paid and received by RiverSource Life Insurance Company were as follows:
|
| | | | | | | |
| Nine Months Ended September 30, |
2018 | | 2017 |
(in millions) |
Cash dividends paid to Ameriprise Financial | $ | 550 |
| | $ | 700 |
|
Cash dividends received from RiverSource Life Insurance Co. of New York (“RiverSource Life of NY”) | 48 |
| | 50 |
|
Cash dividends received from RiverSource Tax Advantaged Investments, Inc. | 45 |
| | 20 |
|
Cash dividends received from RiverSource REO 1, LLC (1) | 2 |
| | — |
|
(1) RiverSource REO 1, LLC is a wholly owned subsidiary of RiverSource Life Insurance Company which holds foreclosed mortgage loans and real estate.
Regulatory Capital
RiverSource Life Insurance Company and RiverSource Life of NY are subject to regulatory capital requirements. Actual capital, determined on a statutory basis, and regulatory capital requirements for each of the life insurance entities were as follows:
|
| | | | | | | | | | | |
| Actual Capital (1) | | Regulatory Capital Requirements (2) |
September 30, 2018 | | December 31, 2017 | December 31, 2017 |
(in millions) |
RiverSource Life Insurance Company | $ | 2,883 |
| | $ | 2,451 |
| | $ | 562 |
|
RiverSource Life Insurance Co. of NY | 245 |
| | 269 |
| | 36 |
|
(1) Actual capital, as defined by the National Association of Insurance Commissioners for purposes of meeting regulatory capital requirements, includes statutory capital and surplus, plus certain statutory valuation reserves.
(2) Regulatory capital requirement is based on the statutory risk-based capital filing.
RIVERSOURCE LIFE INSURANCE COMPANY
Contractual Commitments
There have been no material changes to the Company’s contractual obligations disclosed in the Company’s 2017 10-K.
Forward-Looking Statements
This report contains forward-looking statements that reflect the Company’s plans, estimates and beliefs. The Company’s actual results could differ materially from those described in these forward-looking statements. Examples of such forward-looking statements include:
| |
• | statements of the Company’s plans, intentions, expectations, objectives, or goals, including those related to the introduction, cessation, terms or pricing of new or existing products and services and the consolidated tax rate; |
| |
• | other statements about future economic performance, the performance of equity markets and interest rate variations and the economic performance of the United States and of global markets; and |
| |
• | statements of assumptions underlying such statements. |
The words “believe,” “expect,” “anticipate,” “optimistic,” “intend,” “plan,” “aim,” “will,” “may,” “should,” “could,” “would,” “likely,” “forecast,” “on pace,” “project” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from such statements.
Such factors include, but are not limited to:
| |
• | conditions in the interest rate, credit default, equity market and foreign exchange environments, including changes in valuations, liquidity and volatility; |
| |
• | changes in and the adoption of relevant accounting standards and securities rating agency standards and processes, as well as changes in the litigation and regulatory environment, including ongoing legal proceedings and regulatory actions, the frequency and extent of legal claims threatened or initiated by clients, other persons and regulators, and developments in regulation and legislation, including the rules and regulations implemented or that may be implemented or modified in connection with the Dodd-Frank Wall Street Reform and Consumer Protection Act or in light of the U.S. Department of Labor and other rules and exemptions pertaining to the fiduciary status of investment advice providers to 401(k) plans, plan sponsors, plan participants and the holders of individual retirement or health savings accounts (as well as similar SEC, Certified Financial Planner Board and state fiduciary rules and standards); |
| |
• | the Company’s investment management performance and consumer acceptance of the Company’s products; |
| |
• | effects of competition in the financial services industry, including pricing pressure, the introduction of new products and services and changes in product distribution mix and distribution channels; |
| |
• | changes to the Company’s reputation that may arise from employee or Ameriprise Financial Services, Inc. advisor misconduct, legal or regulatory actions, cybersecurity incidents, improper management of conflicts of interest or otherwise; |
| |
• | the Company’s capital structure as a subsidiary of Ameriprise Financial, including the ability of its parent to support its financial strength and ratings, as well as the opinions of rating agencies and other analysts or the Company’s regulators, distributors or policyholders and contractholders in response to any change or prospect of change in any such opinion; |
| |
• | risks of default, capacity constraint or repricing by issuers or guarantors of investments the Company owns or by counterparties to hedge derivative, insurance or reinsurance arrangements, experience deviations from the Company’s assumptions regarding such risks, the evaluations or the prospect of changes in evaluations of any such third parties published by rating agencies or other analysts and the reactions of other market participants or the Company’s regulators, distribution partners or customers in response to any such evaluation or prospect of changes in evaluation; |
| |
• | experience deviations from the Company’s assumptions regarding morbidity, mortality, persistency and premium rate increases in certain annuity and insurance products (including, but not limited to, variable annuities and long term care policies), or from assumptions regarding market returns assumed in valuing or unlocking DAC and DSIC or market volatility underlying the Company’s valuation and hedging of guaranteed benefit annuity riders, or from assumptions regarding interest rates or asset yield assumed in the Company’s loss recognition testing of its long term care business; |
| |
• | successfully cross-selling insurance and annuity products and services to Ameriprise Financial’s customer base; |
| |
• | the Company’s ability to effectively hedge risks relating to guaranteed benefit riders and certain other products; |
| |
• | the impact of intercompany allocations to the Company from Ameriprise Financial and its affiliates; |
| |
• | Ameriprise Financial’s ability to attract, recruit and retain qualified advisors and employees and its ability to distribute the Company’s products through current and future distribution channels; |
| |
• | changes in capital requirements that may be indicated, required or advised by regulators or rating agencies; |
| |
• | the impacts of Ameriprise Financial’s efforts to improve distribution economics and realize benefits from re-engineering and tax planning; |
| |
• | interruptions or other failures in the Company’s communications, technology and other operating systems, including errors or failures caused by third-party service providers, interference or failures caused by third-party attacks on the Company’s systems |
RIVERSOURCE LIFE INSURANCE COMPANY
(or other cybersecurity incidents), or the failure to safeguard the privacy or confidentiality of sensitive information and data on such systems; and
| |
• | general economic and political factors, including consumer confidence in the economy, the ability and inclination of consumers generally to invest, as well as their ability and inclination to invest in financial instruments and products other than cash and cash equivalents, the costs of products and services the Company consumes in the conduct of its business, and applicable legislation and regulation and changes therein, (such as the uncertain regulatory environment in the U.S. since the 2016 U.S. election), including tax laws, tax treaties, fiscal and central government treasury policy, and policies regarding the financial services industry and regulatory rulings and pronouncements. |
The Company cautions the reader that the foregoing list of factors is not exhaustive. There may also be other risks that the Company is unable to predict at this time that may cause actual results to differ materially from those in forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update publicly or revise any forward-looking statements. The foregoing list of factors should be read in conjunction with the “Risk Factors” discussion included in Part I, Item 1A of the Company’s 2017 10-K.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) designed to provide reasonable assurance that the information required to be reported in the Exchange Act filings is recorded, processed, summarized and reported within the time periods specified in and pursuant to Securities and Exchange Commission regulations, including controls and procedures designed to ensure that this information is accumulated and communicated to the Company’s management, including its principal executive officer and chief financial officer, as appropriate, to allow timely decisions regarding the required disclosure. It should be noted that, because of inherent limitations, the Company’s disclosure controls and procedures, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the disclosure controls and procedures are met.
The Company’s management, under the supervision and with the participation of the Company’s principal executive officer and chief financial officer, evaluated the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the Company’s principal executive officer and chief financial officer have concluded that the Company’s disclosure controls and procedures were effective at a reasonable level of assurance as of September 30, 2018.
Changes in Internal Control over Financial Reporting
There have not been any changes in RiverSource Life Insurance Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, RiverSource Life Insurance Company’s internal control over financial reporting.
RIVERSOURCE LIFE INSURANCE COMPANY
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The information set forth in Note 17 to the Consolidated Financial Statements in Part I, Item 1 is incorporated herein by reference.
ITEM 1A. RISK FACTORS
There have been no material changes in the risk factors provided in Part I, Item 1A of RiverSource Life Insurance Company’s 2017 10-K.
ITEM 6. EXHIBITS
The following exhibits are filed as part of this Quarterly Report:
|
| |
Exhibit | Description |
| |
| Copy of Certificate of Incorporation of IDS Life Insurance Company, filed as Exhibit 3.1 to Post-Effective Amendment No. 5 to Registration Statement No. 33-28976, is incorporated by reference. |
| Copy of Certificate of Amendment of Certificate of Incorporation of IDS Life Insurance Company dated June 22, 2006, filed as Exhibit 3.1 to Form 8-K filed on January 5, 2007, is incorporated by reference. |
| Copy of Amended and Restated By-Laws of RiverSource Life Insurance Company dated June 22, 2006, filed as Exhibit 27(f)(2) to Post-Effective Amendment No. 28 to Registration Statement No. 333-69777, is incorporated by reference. |
| Certification of John R. Woerner, Chairman and President, pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended. |
| Certification of Brian J. McGrane, Chief Financial Officer, pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended. |
| Certification of John R. Woerner, Chairman and President, and Brian J. McGrane, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
101 | The following materials from RiverSource Life Insurance Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2018 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at September 30, 2018 and December 31, 2017; (ii) Consolidated Statements of Income for the three months and nine months ended September 30, 2018 and 2017; (iii) Consolidated Statements of Comprehensive Income for the three months and nine months ended September 30, 2018 and 2017; (iv) Consolidated Statements of Equity for the three months and nine months ended September 30, 2018 and 2017; (v) Consolidated Statements of Cash Flows for the nine months ended September 30, 2018 and 2017; and (vi) Notes to the Consolidated Financial Statements. |
* Filed electronically herewithin. |
RIVERSOURCE LIFE INSURANCE COMPANY
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| | | | | |
| | | | RIVERSOURCE LIFE INSURANCE COMPANY | |
| | | | (Registrant) | |
| | | | | |
| | | | | |
| | | | | |
Date: | November 5, 2018 | | By: | /s/ John R. Woerner | |
| | | | John R. Woerner | |
| | | | Chairman and President | |
| | | | | |
| | | | | |
Date: | November 5, 2018 | | By: | /s/ Brian J. McGrane | |
| | | | Brian J. McGrane | |
| | | | Executive Vice President and | |
| | | | Chief Financial Officer | |